Elizabeth Arden (RDEN) 10-Q 2013 Q3 Quarterly report

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)
[x]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2013
[]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission file number 1-6370

ELIZABETH ARDEN, INC.

(Exact name of registrant as specified in its charter)

Florida	59-0914138
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
2400 S.W. 145 Avenue, Miramar, Florida	33027
(Address of principal executive offices)	(Zip Code)
(954) 364-6900
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes  [X]      No  [  ]
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes  [X]      No  [  ]
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer	[ X]	Accelerated filer	[   ]
Non-accelerated filer	[    ]  (Do not check if a smaller reporting company)	Smaller reporting company	[   ]
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     Yes  [  ]      No  [X]
Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

Class	Outstanding at April 30, 2013
Common Stock, $.01 par value per share	29,477,523

ELIZABETH ARDEN, INC.

INDEX TO FORM 10-Q

PART I	FINANCIAL INFORMATION
Item 1.	Financial Statements	Page No.
	Unaudited Consolidated Balance Sheets -- March 31, 2013 and June 30, 2012	3
	Unaudited Consolidated Statements of Operations -- Three and nine months ended March 31, 2013 and March 31, 2012	4
	Unaudited Consolidated Statements of Comprehensive (Loss) Income -- Three and nine months ended March 31, 2013 and March 31, 2012	5
	Unaudited Consolidated Statement of Shareholders' Equity -- Nine months ended March 31, 2013	6
	Unaudited Consolidated Statements of Cash Flow -- Nine months ended March 31, 2013 and March 31, 2012	7
	Notes to Unaudited Consolidated Financial Statements	8
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	33
Item 4.	Controls and Procedures	34
PART II	OTHER INFORMATION
Item 1A.	Risk Factors	34
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 5.	Other Information	35
Item 6.	Exhibits	36
Signatures		39
Exhibit Index		40

- 2 -

PART I      FINANCIAL INFORMATION
ITEM 1.     FINANCIAL STATEMENTS

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Amounts in thousands, except shares and par value)

			As of
			March 31, 2013			June 30, 2012
ASSETS
Current Assets
	Cash and cash equivalents		$	31,442		$	59,080
	Accounts receivable, net			230,757			188,141
	Inventories			326,430			291,987
	Deferred income taxes			31,853			40,706
	Prepaid expenses and other assets			42,279			44,583
		Total current assets		662,761			624,497
Property and equipment, net				96,166			89,438
Exclusive brand licenses, trademarks and intangibles, net				301,061			314,502
Goodwill				21,054			21,054
Debt financing costs, net				6,879			7,903
Deferred income taxes				2,206			1,866
Other				14,208			7,494
		Total assets	$	1,104,335		$	1,066,754
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities
	Short-term debt		$	116,250		$	89,200
	Accounts payable - trade			81,099			77,961
	Other payables and accrued expenses			85,962			111,518
		Total current liabilities		283,311			278,679
Long-term Liabilities
	Long-term debt			250,000			250,000
	Deferred income taxes and other liabilities			45,612			56,348
		Total long-term liabilities		295,612			306,348
		Total liabilities		578,923			585,027
Commitments and contingencies (see Note 9)
Shareholders' Equity
	Common stock, $.01 par value, 50,000,000 shares authorized; 34,154,728 and    33,788,871 shares issued, respectively			341			338
	Additional paid-in capital			348,604			337,740
	Retained earnings			263,074			217,354
	Treasury stock (4,676,082 and 4,353,200 shares at cost, respectively)			(87,386	)		(74,871	)
	Accumulated other comprehensive income			779			1,166
		Total shareholders' equity		525,412			481,727
		Total liabilities and shareholders' equity	$	1,104,335		$	1,066,754

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 3 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(Amounts in thousands, except per share data)

	Three Months Ended						Nine Months Ended
	March 31, 2013			March 31, 2012			March 31, 2013		March 31, 2012
Net sales	$	264,484		$	239,279		$	1,076,944	$	972,739
Cost of goods sold:
Cost of sales		136,643			118,781			562,220		489,548
Depreciation related to cost of goods sold		1,656			906			4,674		3,850
Total cost of goods sold		138,299			119,687			566,894		493,398
Gross profit		126,185			119,592			510,050		479,341
Operating expenses:
Selling, general and administrative		111,597			104,582			404,257		371,480
Depreciation and amortization		10,254			7,645			28,755		21,433
Total operating expenses		121,851			112,227			433,012		392,913
Income from operations		4,334			7,365			77,038		86,428
Interest expense, net		5,893			5,291			18,515		16,339
(Loss) income before income taxes		(1,559	)		2,074			58,523		70,089
(Benefit from) provision for income taxes		(286	)		(117	)		12,803		16,295
Net (loss) income	$	(1,273	)	$	2,191		$	45,720	$	53,794
Net (loss) income per common share:
Basic	$	(0.04	)	$	0.08		$	1.54	$	1.85
Diluted	$	(0.04	)	$	0.07		$	1.50	$	1.79
Weighted average number of common shares:
Basic		29,607			29,116			29,658		29,017
Diluted		29,607			30,069			30,498		29,997

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 4 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(Unaudited)

(Amounts in thousands)

		Three Months Ended						Nine Months Ended
		March 31, 2013			March 31, 2012			March 31, 2013			March 31, 2012
Net (loss) income		$	(1,273	)	$	2,191		$	45,720		$	53,794
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments(1)			(2,226	)		2,101			(1,157	)		(3,536	)
Net unrealized cash flow hedging gain (loss)(2)			752			(488	)		770			1,544
Total other comprehensive (loss) income, net of tax			(1,474	)		1,613			(387	)		(1,992	)
Comprehensive (loss) income		$	(2,747	)	$	3,804		$	45,333		$	51,802
(1)	Foreign currency translation adjustments are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries.
(2)	Net of tax expense of $77 for the three months ended March 31, 2013 and net of tax benefit of $101 for the three months ended March 31, 2012. Net of tax expense of $19 and $585 for the nine months ended March 31, 2013 and 2012, respectively.

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 5 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

(Unaudited)

(Amounts in thousands)

	Common Stock				Additional Paid-in			Retained		Treasury Stock					Accumulated Other Comprehensive			Total Shareholders' Equity
	Shares		Amount		Capital			Earnings		Shares		Amount			Income
Balance as of July 1, 2012	33,789		$	338	$	337,740		$	217,354	(4,353	)	$	(74,871	)	$	1,166		$	481,727
Issuance of common stock upon exercise of options,    net of tax withholdings of $1,444	359			3		3,246			--	--			--			--			3,249
Issuance of common stock for employee stock purchase plan	37			--		1,057			--	--			--			--			1,057
Restricted stock, forfeitures and tax withholdings	(30	)		--		(2,748	)		--	--			--			--			(2,748	)
Amortization of share-based awards	--			--		4,247			--	--			--			--			4,247
Repurchase of common stock	--			--		--			--	(323	)		(12,515	)		--			(12,515	)
Excess tax benefit from share-based awards	--			--		5,062			--	--			--			--			5,062
Net Income	--			--		--			45,720	--			--			--			45,720
Foreign currency translation adjustments	--			--		--			--	--			--			(1,157	)		(1,157	)
Net unrealized cash flow hedging gain	--			--		--			--	--			--			770			770
Balance as of March 31, 2013	34,155		$	341	$	348,604		$	263,074	(4,676	)	$	(87,386	)	$	779		$	525,412

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 6 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOW

(Unaudited)

(Dollars in thousands)

				Nine Months Ended
				March 31, 2013			March 31, 2012
Operating Activities:
	Net income			$	45,720		$	53,794
	Adjustments to reconcile net income to net cash (used in) provided by operating activities:
		Depreciation and amortization			33,429			25,283
		Amortization of senior note offering and credit facility costs			1,024			931
		Amortization of share-based awards			4,247			3,758
		Deferred income taxes			6,371			11,883
Changes in assets and liabilities, net of acquisitions:
		Increase in accounts receivable			(42,867	)		(8,915	)
		Increase in inventories			(34,763	)		(27,323	)
		Decrease (increase) in prepaid expenses and other assets			2,936			(1,944	)
		Increase in accounts payable			8,200			19,023
		Decrease in other payables, accrued expenses and other liabilities			(33,263	)		(26,075	)
		Other			118			(84	)
			Net cash (used in) provided by operating activities		(8,848	)		50,331
Investing Activities:
	Additions to property and equipment				(30,388	)		(16,785	)
	Acquisition of intangibles and other assets				(8,068	)		(43,900	)
			Net cash used in investing activities		(38,456	)		(60,685	)
Financing Activities:
	Proceeds from short-term debt				27,050			--
	Repurchase of common stock				(12,515	)		--
	Proceeds from the exercise of stock options				4,693			5,258
	Proceeds from the issuance of common stock under the employee stock    purchase plan				1,057			958
	Payments of contingent consideration related to acquisition				(4,960	)		--
	Excess tax benefit from share-based awards				5,085			4,703
			Net cash provided by financing activities		20,410			10,919
Effect of exchange rate changes on cash and cash equivalents					(744	)		(1,208	)
Net decrease in cash and cash equivalents					(27,638	)		(643	)
Cash and cash equivalents at beginning of period					59,080			58,850
Cash and cash equivalents at end of period				$	31,442		$	58,207
Supplemental Disclosure of Non-Cash Information:
	Additions to property and equipment not paid for (not included above)			$	353		$	384

The accompanying notes are an integral part of the unaudited consolidated financial statements.

- 7 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1.    BUSINESS AND BASIS OF PRESENTATION

          Elizabeth Arden, Inc. (the "Company" or "our") is a global prestige beauty products company that sells fragrances, skin care and cosmetic products to retailers in the United States and approximately 120 countries internationally.

          The unaudited consolidated financial statements include the accounts of the Company's wholly-owned domestic and international subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying unaudited consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the "Commission") for interim financial information. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statement presentation and should be read in conjunction with the audited consolidated financial statements and related footnotes included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2012 (the "2012 Annual Report"), filed with the Commission.

          The consolidated balance sheet of the Company as of June 30, 2012 is derived from the financial statements included in the 2012 Annual Report but does not include all disclosures required by accounting principles generally accepted in the United States. The consolidated financial statements presented in this quarterly report are unaudited but include all adjustments that are of a normal recurring nature that management considers necessary for the fair statement of the results for the interim periods. Results for interim periods are not necessarily indicative of results for the full fiscal year.

NOTE 2.    ACCUMULATED OTHER COMPREHENSIVE INCOME

          The Company's accumulated other comprehensive income shown on the accompanying consolidated balance sheets consists of foreign currency translation adjustments, which are not adjusted for income taxes since they relate to indefinite investments in non-U.S. subsidiaries, and the unrealized gains, net of taxes, related to the Company's foreign currency contracts.

          The components of accumulated other comprehensive income were as follows:

(Amounts in thousands		March 31, 2013			June 30, 2012
Cumulative foreign currency translation adjustments		$	(160	)	$	997
Net unrealized hedging gains, net of taxes(1)			939			169
Accumulated other comprehensive income		$	779		$	1,166
(1)	Net of tax expense of $55 and $35 as of March 31, 2013 and June 30, 2012, respectively.

NOTE 3.    (LOSS) INCOME PER SHARE

          Basic net (loss) income per share is computed by dividing the net (loss) income by the weighted average number of shares of the Company's outstanding common stock, $.01 par value per share ("Common Stock"). The calculation of net (loss) income per diluted share is similar to basic net (loss) income per share except that the denominator includes potentially dilutive Common Stock equivalents, such as stock options and non-vested restricted stock or restricted stock units. For the three months ended March 31, 2013, diluted loss per share equals basic loss per share as the assumed exercise of stock options, non-vested restricted stock and restricted stock units, and the assumed purchases under the employee stock purchase plan would have an anti-dilutive effect.

- 8 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          The following table represents the computation of net (loss) income per share:

(Amounts in thousands, except per share data)		Three Months Ended					Nine Months Ended
		March 31, 2013			March 31, 2012		March 31, 2013		March 31, 2012
Basic
	Net (loss) income	$	(1,273	)	$	2,191	$	45,720	$	53,794
	Weighted average shares outstanding		29,607			29,116		29,658		29,017
	Net (loss) income per basic share	$	(0.04	)	$	0.08	$	1.54	$	1.85
Diluted
	Net (loss) income	$	(1,273	)	$	2,191	$	45,720	$	53,794
	Weighted average shares outstanding		29,607			29,116		29,658		29,017
	Potential common shares - treasury    method		--			953		840		980
	Weighted average shares and potential    dilutive common shares		29,607			30,069		30,498		29,997
	Net (loss) income per diluted share	$	(0.04	)	$	0.07	$	1.50	$	1.79

         The following table shows the number of Common Stock equivalents subject to option awards that were outstanding for the three and nine months ended March 31, 2013 and 2012 that were not included in the diluted net (loss) income per share calculation because to do so would have been anti-dilutive:

(Amounts in thousands)	Three Months Ended				Nine Months Ended
	March 31, 2013		March 31, 2012		March 31, 2013		March 31, 2012
Number of shares		830		--		90		--

NOTE 4.    NEW ACCOUNTING STANDARDS AND NEW TAX LEGISLATION

Comprehensive Income

          On July 1, 2012, theCompany adopted the updated guidance to Topic 220, Comprehensive Income, issued by the Financial Accounting Standards Board ("FASB"). This update required companies to present comprehensive income in either one or two consecutive financial statements and eliminated the option that permits the presentation of other comprehensive income in the consolidated statement of shareholders' equity. The Company adopted the method of presentation using two consecutive financial statements.

          In January 2013, the FASB issued another update to the guidance in Topic 220. This update does not change the requirements for reporting net income or other comprehensive income in financial statements, but rather improves the transparency of reporting reclassifications out of accumulated other comprehensive income. The new guidance is effective for the Company beginning July 1, 2013, and adoption is not expected to have a material impact on the Company's consolidated financial statements or disclosures.

Testing Indefinite-Lived Intangible Assets for Impairment.

          In July 2012, the FASB issued an update to Codification Topic 350, Intangibles- Goodwill and Other: Testing Indefinite-Lived Intangible Assets for Impairment. The update simplifies the guidance for testing impairment of indefinite-lived intangible assets other than goodwill. Examples of intangible assets subject to the guidance include indefinite-lived trademarks, licenses, and distribution rights. The amendment allows a company the option to first assess qualitative factors to determine whether it is necessary to perform

- 9 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

the quantitative impairment test. A company electing to perform a qualitative assessment is no longer required to calculate the fair value of an indefinite-lived intangible asset unless the company determines, based on such qualitative assessment, that it is "more likely than not" that the asset is impaired. The changes to Codification Topic 350 will be effective for the Company beginning July 1, 2013, with early adoption permitted. The Company has the option to adopt the updated guidance in Topic 350 for its annual impairment test to be performed during the fourth quarter of the current fiscal year and adoption of the updated guidance is not expected to have a material impact on the Company's consolidated financial statements or disclosures.

American Taxpayer Relief Act of 2012

          On January 2, 2013, the American Taxpayer Relief Act of 2012 was signed into law by the President of the United States. Under the provisions of the American Taxpayer Relief Act of 2012, the research and development tax credit that had expired December 31, 2011, was reinstated retroactively to January 1, 2012, and is now scheduled to expire on December 31, 2013. The Company recorded the impact of the extension of the research and development tax credit in the fiscal quarter beginning January 1, 2013. The impact of the extension of such tax credit is expected to result in a net tax benefit of approximately $0.5 million for the fiscal year ending June 30, 2013, of which $0.2 million was recorded as a discrete item in the third quarter of fiscal 2013.

NOTE 5.    INVENTORIES

          The components of inventory were as follows:

(Amounts in thousands)	March 31, 2013		June 30, 2012
Raw materials	$	67,811	$	55,362
Work in progress		18,306		19,650
Finished goods		240,313		216,975
Total	$	326,430	$	291,987

NOTE 6.    EXCLUSIVE BRAND LICENSES, TRADEMARKS AND INTANGIBLES, NET AND GOODWILL

          The following summarizes the cost basis amortization and weighted average estimated life associated with the Company's intangible assets:

(Amounts in thousands)		March 31, 2013			June 30, 2012			June 30, 2012 Weighted Average Estimated Life
Elizabeth Arden brand trademarks		$	122,415		$	122,415		Indefinite
Exclusive brand licenses and related trademarks			179,408			178,555		13
Exclusive brand trademarks			100,804			100,313		17
Other intangibles(1)			16,000			16,000		20
Exclusive brand licenses, trademarks and intangibles, gross			418,627			417,283
Accumulated amortization:
Exclusive brand licenses and related trademarks			(64,832	)		(53,486	)
Exclusive brand trademarks			(47,455	)		(44,687	)
Other intangibles			(5,279	)		(4,608	)
Exclusive brand licenses, trademarks and intangibles, net		$	301,061		$	314,502
(1)	Primarily consists of customer relationships, customer lists and non-compete agreements.

          At March 31, 2013, the Company had goodwill of $21.1 million recorded on its consolidated balance sheet. The entire amount of the goodwill in all periods presented relates to the North America segment. The amount of goodwill recorded on the consolidated balance sheet at March 31, 2013 did not change from the prior fiscal year end balance as the Company did not record any additions or impairments during the nine months ended March 31, 2013.

- 10 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          Amortization expense was $4.8 million and $2.5 million for the three months ended March 31, 2013 and 2012, respectively, and $14.8 million and $7.4 million for the nine months ended March 31, 2013 and 2012, respectively. At March 31, 2013, the Company estimated annual amortization expense for the Company's intangible assets for each of the next five fiscal years to be as shown in the following table. Future acquisitions, renewals or impairment events could cause these amounts to change.

(Amounts in millions)	Remainder of 2013		2014		2015		2016		2017
Amortization expense	$	4.7	$	19.1	$	18.5	$	17.8	$	16.4

NOTE 7.    OTHER PAYABLES AND ACCRUED EXPENSES

          A summary of the Company's other payables and accrued expenses is as follows:

(Amounts in thousands)	March 31, 2013		June 30, 2012
Accrued advertising, promotion and royalties	$	32,895	$	27,774
Accrued employee-related benefits		14,138		28,288
Accrued value added taxes		6,217		5,017
Accrued interest		1,497		5,819
Other accruals		31,215		44,620
Total other payables and accrued expenses	$	85,962	$	111,518

NOTE 8.    SHORT-TERM DEBT

             The Company has a $300 million revolving bank credit facility ("the Credit Facility") with a syndicate of banks, for which JPMorgan Chase Bank is the administrative agent, which generally provides for borrowings on a revolving basis, with a sub-limit of $25 million for letters of credit. Under the terms of the Credit Facility, the Company may, at any time, increase the size of the Credit Facility up to $375 million without entering into a formal amendment requiring the consent of all of the banks, subject to the Company's satisfaction of certain conditions. The credit facility expires in January 2016.

          The Credit Facility is guaranteed by all of the Company's U.S. subsidiaries and is collateralized by a first priority lien on all of the Company's U.S. accounts receivable and inventory. Borrowings under the Credit Facility are limited to 85% of eligible accounts receivable and 85% of the appraised net liquidation value of the Company's inventory, as determined pursuant to the terms of the Credit Facility; provided, however, that from August 15 to October 31 of each year the Company's borrowing base may be temporarily increased by up to $25 million.

          The Credit Facility has only one financial maintenance covenant, which is a debt service coverage ratio that must be maintained at not less than 1.1 to 1 if average borrowing base capacity declines to less than $25 million ($35 million from September 1 through January 31). The Company's average borrowing base capacity during the quarter ended March 31, 2013, did not fall below the applicable threshold noted above. Accordingly, the debt service coverage ratio did not apply for the quarter ended March 31, 2013.

          Under the terms of the Credit Facility, the Company may pay dividends or repurchase Common Stock if it maintains borrowing base capacity of at least $25 million from February 1 to August 31, and at least $35 million from September 1 to January 31, after making the applicable payment. The Credit Facility restricts the Company from incurring additional non-trade indebtedness (other than refinancings and certain small amounts of indebtedness).

          Borrowings under the credit portion of the Credit Facility bear interest at a floating rate based on an "Applicable Margin" which is determined by reference to a debt service coverage ratio. At the Company's option, the Applicable Margin may be applied to either the London InterBank Offered Rate ("LIBOR") or the base rate (which is comparable to prime rates). The Applicable Margin ranges from 1.75% to 2.50% for LIBOR loans, and from 0.25% to 1.0% for base rate loans, except that the Applicable Margin on the first $25 million of borrowings from August 15 to October 31 of each year, while the temporary increase in the Company's borrowing base is in effect, is 1.0% higher. The Company is required to pay an unused commitment fee ranging from 0.375% to 0.50% based on the quarterly average unused portion of the Credit Facility.

- 11 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          At March 31, 2013, the Applicable Margin was 1.75% for LIBOR loans and 0.25% for base rate loans. The commitment fee on the unused portion of the Credit Facility at March 31, 2012 was 0.50%. For both the nine months ended March 31, 2013 and 2012, the weighted average annual interest rate on borrowings under the Credit Facility was 2.1%.

          In connection with the 2012 acquisitions of fragrance licenses and certain other assets from New Wave Fragrances LLC and Give Back Brands LLC, on June 12, 2012, the Company entered into a second lien credit agreement with JPMorgan Chase Bank, N.A. providing the Company with the ability to borrow up to $30 million on or prior to July 2, 2012 (the "Second Lien Facility"). On July 2, 2012, the Company borrowed $30 million under the Second Lien Facility and used the proceeds to repay amounts under the Credit Facility. The Second Lien Facility is collateralized by a second priority lien on all of the Company's U.S. accounts receivable and inventories and the interest on borrowings charged under the Second Lien Facility was either (i) LIBOR plus an applicable margin of 3.75% or (ii) the base rate specified in the Second Lien Facility (which is comparable to prime rates) plus a margin of 2.75%. The Company had the option to prepay all or a portion of the Second Lien Facility anytime after February 1, 2013, provided the borrowing availability under the Credit Facility was in excess of $35 million after giving effect to the applicable prepayment each day for the 30 day period ending on the date of the prepayment. The Second Lien Facility matures on July 2, 2014.

          On February 11, 2013, the Company prepaid all of the amounts outstanding under the Second Lien Facility and amended the Second Lien Facility to allow for borrowings of up to $30 million on a revolving basis until its maturity. The amendment also reduced the interest on borrowings on the Second Lien Facility to (i) LIBOR plus an applicable margin of 3.25% or (ii) the base rate specified in the Second Lien Facility (which is comparable to prime rates) plus a margin of 1.75%. The unused commitment fee applicable to the Second Lien Facility ranges from 0.25% to 0.375%. To the extent the Company borrows amounts under the Second Lien Facility, the Company has the option to prepay all or a portion of such borrowings, provided the borrowing base capacity under the Credit Facility is in excess of $35 million after giving effect to the applicable prepayment each day for the 30 day period ending on the date of the prepayment. In periods when there are outstanding borrowings, the Company classifies the Credit Facility and Second Lien Facility as short term debt on its balance sheet because it expects to reduce outstanding borrowings over the next twelve months. At March 31, 2013, the Company had no outstanding borrowings under the Second Lien Facility.

          At March 31, 2013, the Company had $116.3 million in outstanding borrowings and approximately $3.3 million in letters of credit outstanding under the Credit Facility compared with $89.2 million in borrowings and $4.4 million in letters of credit outstanding at June 30, 2012. At March 31, 2013, based on eligible accounts receivable and inventory available as collateral, an additional $77.3 million in the aggregate could be borrowed under the Credit Facility and the Second Lien Facility.

NOTE 9.    COMMITMENTS AND CONTINGENCIES

          In September, 2012, the Company invested $5.5 million, including transaction costs, for a minority investment in Elizabeth Arden Salon Holdings, LLC, an unrelated party whose subsidiaries operate the Elizabeth Arden Red Door Spas and the Mario Tricoci Hair Salons ("Salon Holdings"). In November 2012, the Company invested an additional $2.1 million. The investment, which is in the form of a secured convertible note bearing interest at 2%, has been accounted for using the cost method and at March 31, 2013, is included in other assets on the unaudited Consolidated Balance Sheet.  Under the terms of the agreement with Salon Holdings, the Company expects to invest an additional $2.1 million in fiscal 2014. The Company entered into a co-investment agreement with another minority investor of Salon Holdings under which the minority investor has the ability to put its interest in Salon Holdings to the Company under certain circumstances, at a specified price based on the performance of Salon Holdings over the previous 12 month period. Should the minority investor put its interest in Salon Holdings to the Company, it can elect to receive payment in cash, Common Stock or a combination of both. As of March 31, 2013, if the minority investor had put its interest in Salon Holdings to the Company, based on the performance of Salon Holdings over the previous 12 month period, the impact would not have been material to the Company's liquidity.

          The Company is a party to a number of legal actions, proceedings, audits, tax audits, claims and disputes, arising in the ordinary course of business, including those with current and former customers over amounts owed. While any action, proceeding, audit or claim contains an element of uncertainty and may materially affect the Company's cash flows and results of operations in a particular quarter or year, based on current facts and circumstances, the Company's management believes that the outcome of such actions, proceedings, audits, claims and disputes will not have a material adverse effect on the Company's business, prospects, results of operations, financial condition or cash flows.

- 12 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          The Company and its domestic subsidiaries file income tax returns with federal, state and local tax authorities within the United States. The Company also files tax returns for its international affiliates in various foreign jurisdictions. The statute of limitations for the Company's U.S. federal tax return years remains open for the year ended June 30, 2008 and subsequent fiscal years. The Internal Revenue Service ("IRS") began an examination of the Company's U.S. federal tax returns for the years ended June 30, 2008 ("Fiscal 2008") and June 30, 2009 ("Fiscal 2009") during fiscal year 2011 and, in November 2012 issued a Notice of Proposed Adjustment ("NOPA") for Fiscal 2008 and Fiscal 2009 relating to transfer pricing matters. In the NOPA, the IRS proposes increases to the Company's U.S. taxable income for Fiscal 2008 and Fiscal 2009 totaling approximately $29.1 million of additional taxable income, which could be material to the Company's consolidated statements of operations in the period in which resolved unless resolved favorably to the Company. The Company disagrees with the proposed adjustments and intends to vigorously contest them and pursue its available remedies. While any IRS examination contains an element of uncertainty, based on current facts and circumstances, the Company believes the ultimate outcome of any protest, appeals or judicial process, will not have a material adverse effect on the Company's financial condition, business or prospects. In addition, if the examination is not resolved favorably, the Company has $71 million of U.S. federal operating loss carryforwards as of June 30, 2012 which would be utilized to offset any cash flow impact. It is reasonably possible that over the next twelve-month period the Company may experience an increase or decrease in its unrecognized tax benefits, but it is not possible to determine either the magnitude or range of any increase or decrease at this time.

          In connection with the acquisition of global licenses and certain assets from Give Back Brands LLC in June 2012, the Company agreed to pay Give Back Brands LLC up to an additional $28 million subject to the achievement of specified sales targets for the acquired brands over a three-year period from July 1, 2012 through June 30, 2015. As part of the accounting for the acquisition, the Company had established a liability for the potential payment of $28 million based upon the probability of achieving the specified sales targets. Based on results for the six months ended December 31, 2012, conditions for payment of the first $5 million installment were satisfied, and such installment was paid during the third quarter of fiscal 2013.

          In connection with the acquisition of global licenses and certain assets from New Wave Fragrances, LLC in May 2012, $2 million of the purchase price was retained by the Company and was scheduled to be paid in the third quarter of fiscal 2013, subject to the settlement of certain post-closing adjustments. The full $2 million of the purchase price retained by the Company was offset by post-closing adjustments. Accordingly, no payment was made to New Wave Fragrances, LLC in the third quarter of fiscal 2013.

NOTE 10.FAIR VALUE MEASUREMENTS

          Accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The accounting standards also have established a fair value hierarchy, which prioritizes the inputs to valuation techniques used in measuring fair value into three broad levels as follows:

Level 1 -	Quoted prices in active markets for identical assets or liabilities
Level 2 -	Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly
Level 3 -	Unobservable inputs based on the Company's own assumptions

          The Company's long-term debt consists of $250 million aggregate principal amount of its 7 3/8% Senior Notes due 2021 (the "7 3/8% Senior Notes"). At March 31, 2013 and June 30, 2012, the estimated fair value of the 7 3/8% Senior Notes was as follows:

(Amounts in thousands)	March 31, 2013		June 30, 2012
7 3/8% Senior Notes due March 2021 (Level 2)	$	278,750	$	271,875

          The Company determined the estimated fair value amounts by using available market information and commonly accepted valuation methodologies. However, considerable judgment is required in interpreting market data to develop estimates of fair value, primarily due to the illiquid nature of the capital markets in which the 7 3/8% Senior Notes are traded. The use of different assumptions and/or estimation methodologies may have a material effect on the estimated fair value.

- 13 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          The Company's derivative assets and liabilities are currently composed of foreign currency contracts. Fair values are based on market prices or determined using valuation models that use as their basis readily observable market data that is actively quoted and can be validated through external sources, including independent pricing services, brokers and market transactions.

          The following table presents the fair value hierarchy for the Company's financial assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2013 and June 30, 2012:

(Amounts in thousands)	March 31, 2013				June 30, 2012
	Asset		Liability		Asset		Liability
Level 2	$	1,200	$	207	$	586	$	382
Total	$	1,200	$	207	$	586	$	382

          See Note 11 for a discussion of the Company's foreign currency contracts.

          Accounting standards require non-financial assets and liabilities to be recognized at fair value subsequent to initial recognition when they are deemed to be other-than-temporarily impaired. As of March 31, 2013, the Company did not have any non-financial assets and liabilities measured at fair value.

NOTE 11.    DERIVATIVE FINANCIAL INSTRUMENTS

          The Company operates in several foreign countries, which exposes it to market risk associated with foreign currency exchange rate fluctuations. The Company's risk management policy is to enter into cash flow hedges to reduce a portion of the exposure of the Company's foreign subsidiaries' revenues to fluctuations in currency rates using foreign currency forward contracts. The Company also enters into cash flow hedges for a portion of its forecasted inventory purchases to reduce the exposure of its Canadian and Australian subsidiaries' cost of sales to such fluctuations, as well as cash flow hedges for a portion of its subsidiaries' forecasted Swiss franc operating costs. The principal currencies hedged are British pounds, Euros, Canadian dollars, Australian dollars and Swiss francs. The Company does not enter into derivative financial contracts for speculative or trading purposes. The Company's derivative financial instruments are recorded in the consolidated balance sheets at fair value determined using pricing models based on market prices or determined using valuation models that use as their basis readily observable market data that is actively quoted and can be validated through external sources, including independent pricing services, brokers and market transactions. Cash flows from derivative financial instruments are classified as cash flows from operating activities in the consolidated statements of cash flows.

          Foreign currency contracts used to hedge forecasted revenues are designated as cash flow hedges. These contracts are used to hedge forecasted subsidiaries' revenues generally over approximately 12 to 24 months. Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive income within shareholders' equity to the extent such contracts are effective, and are recognized in net sales in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three and nine months ended March 31, 2013 or in fiscal 2012 relating to foreign currency contracts used to hedge forecasted revenues resulting from hedge ineffectiveness. As of March 31, 2013, the Company had notional amounts of 8.3 million British pounds and 12.5 million Euros under foreign currency contracts used to hedge forecasted revenues, all of which expire between April 30, 2013 and May 31, 2014.

          Foreign currency contracts used to hedge forecasted cost of sales or operating costs are designated as cash flow hedges. These contracts are used to hedge the forecasted cost of sales of the Company's Canadian and Australian subsidiaries or operating costs of the Company's Swiss subsidiaries generally over approximately 12 to 24 months. Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive income within shareholders' equity, to the extent such contracts are effective, and are recognized in cost of sales or selling, general and administrative expenses in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three and nine months ended March 31, 2013 or in fiscal 2012 relating to foreign currency contracts used to hedge forecasted cost of sales or forecasted operating costs resulting from hedge ineffectiveness. As of March 31, 2013, the Company had notional amounts under foreign currency contracts of (i) 1.1 million Canadian dollars and 1.0 million Australian dollars used to hedge forecasted cost of sales, and (ii) 14.7 million Swiss francs used to hedge forecasted operating costs, all of which expire between April 30, 2013 and May 31, 2014.

- 14 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          When appropriate, the Company also enters into and settles foreign currency contracts for Euros, British pounds, Canadian dollars and Australian dollars to reduce exposure of the Company's foreign subsidiaries' balance sheets to fluctuations in foreign currency rates. These contracts are used to hedge balance sheet exposure generally over one month and are settled before the end of the month in which they are entered into. Changes to fair value of the forward contracts are recognized in selling, general and administrative expense in the period in which the contracts expire. For the three and nine months ended March 31, 2013, the Company recorded gains of $0.7 million and $20,000, respectively in selling, general and administrative expenses related to these contracts. For the three and nine months ended March 31, 2012, the Company recorded losses of $0.6 million and a gain of $11,000, respectively, in selling, general and administrative expenses related to these contracts. As of March 31, 2013, there were no such foreign currency contracts outstanding. There were no amounts recorded in the three and nine months ended March 31, 2013 or in fiscal 2012 relating to foreign currency contracts to hedge subsidiary balance sheets resulting from hedge ineffectiveness.

          The following tables illustrate the fair value of outstanding foreign currency contracts and the gains (losses) associated with the settlement of these contracts:

(Amounts in thousands)	Fair Value of Derivative Instruments Designated as Effective Hedges
Balance Sheet Location	March 31, 2013		June 30, 2012
Other assets	$	1,200	$	586
Other payables	$	207	$	382

Gain (Loss) Reclassified from Accumulated Other Comprehensive Income into Income, Net of Tax (Effective Portion)

(Amounts in thousands)		Three Months Ended						Nine Months Ended
		March 31, 2013			March 31, 2012			March 31, 2013			March 31, 2012
Currency Contracts - Sales(1)		$	28		$	102		$	(145	)	$	163
Currency Contracts - Cost of Sales(2)			(25	)		(241	)		(270	)		(805	)
Currency Contracts - Selling, General and Administrative Expenses(3)			45			12			15			12
Total(4)		$	48		$	(127	)	$	(400	)	$	(630	)
(1)	Recorded in net sales on the consolidated statements of income.
(2)	Recorded in cost of sales on the consolidated statements of income.
(3)	Recorded in selling, general and administrative expenses on the consolidated statements of income.
(4)	Net of tax benefit of $5 and $89 for the three months ended March 31, 2013 and 2012, respectively. Net of tax benefit of $132 and $316 for the nine months ended March 31, 2013 and 2012, respectively.

Net Gain (Loss) Recognized in Other Comprehensive Income on Derivatives, Net of Tax (Effective Portion)

(Amounts in thousands)		Three Months Ended						Nine Months Ended
		March 31, 2013			March 31, 2012			March 31, 2013		March 31, 2012
Currency Contracts-Sales		$	1,323		$	(879	)	$	897	$	(376	)
Currency Contracts - Cost of Sales			28			54			53		2,162
Currency Contracts - Selling, General    and Administrative Expenses			(647	)		464			220		388
Total(1)		$	704		$	(361	)	$	1,170	$	2,174
(1)	Net of tax expense of $82 for the three months ended March 31, 2013 and net of tax benefit of $12 for the three months ended March 31, 2012. Net of tax expense of $151 and $901 for the nine months ended March 31, 2013 and 2012, respectively.

- 15 -

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 12.    REPURCHASES OF COMMON STOCK

          On November 2, 2010, the Company's board of directors authorized the repurchase of an additional $40 million of Common Stock under the terms of an existing $80 million common stock repurchase program and extended the term of the stock repurchase program from November 30, 2010 to November 30, 2012. On August 7, 2012, the Company's board of directors approved an extension of the stock repurchase program through November 30, 2014.

          During the three months ended March 31, 2013, the Company purchased 322,882 shares of Common Stock on the open market under the stock repurchase program at an average price of $38.76 per share and at a cost of $12.5 million, including sales commissions. As of March 31, 2013, the Company had repurchased 4,352,083 shares of Common Stock on the open market under the stock repurchase program, at an average price of $18.27 per share and at a cost of approximately $79.5 million, including sales commissions, leaving approximately $40.5 million available for additional repurchases under the program. The acquisition of these shares by the Company was accounted for under the treasury method.

NOTE 13.    SEGMENT DATA AND RELATED INFORMATION

          Reportable operating segments,as defined by Codification Topic 280,Segment Reporting, include components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (the "Chief Executive") in deciding how to allocate resources and in assessing performance. As a result of the similarities in the procurement, marketing and distribution processes for all of the Company's products, much of the information provided in the consolidated financial statements is similar to, or the same as, that reviewed on a regular basis by the Chief Executive.

          The Company's operations are organized into the following two operating segments, which also comprise the Company's reportable segments:

— North America- The North America segment sells the Company's portfolio of owned, licensed and distributed brands, including the Elizabeth Arden products, to department stores, mass retailers and distributors in the United States, Canada and Puerto Rico, and also includes the Company's direct to consumer business, which is composed of the Elizabeth Arden branded retail outlet stores and the Company's global e-commerce business. This segment also sells the Elizabeth Arden products through the Red Door beauty salons and spas, which are owned and operated by a third party in which the Company has a minority investment that licenses the Elizabeth Arden and Red Door trademarks from the Company for use in its salons and spas.

— International - The International segment sells the Company's portfolio of owned and licensed brands, including the Elizabeth Arden products, in approximately 120 countries outside of North America to perfumeries, boutiques, department stores, travel retail outlets and distributors.

          The Chief Executive evaluates segment profit based upon income from operations, which represents earnings before income taxes, interest expense and depreciation and amortization charges. The accounting policies for each of the reportable segments are the same as those described in the Company's 2012 Annual Report under Note 1 -- "General Information and Summary of Significant Accounting Policies."

          The assets and liabilities of the Company are managed centrally and are reported internally in the same manner as the consolidated financial statements; thus, no additional information regarding assets and liabilities of the Company's reportable segments is produced for the Chief Executive or included herein.

          Segment profit (loss) excludes depreciation and amortization, interest expense, consolidation and elimination adjustments and unallocated corporate expenses, which are shown in the table reconciling segment profit to consolidated income before income taxes. Included in unallocated corporate expenses are (i) restructuring charges that are related to an announced plan, (ii) restructuring costs for corporate operations, and (iii) acquisition-related costs including transition costs. These expenses are recorded in unallocated corporate expenses as these items are centrally directed and controlled and are not included in internal measures of segment operating performance. The Company does not have any intersegment sales.

- 16-

ELIZABETH ARDEN, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

          The following table is a comparative summary of the Company's net sales and segment (loss) profit by operating segment for the three and nine months ended March 31, 2013 and 2012:

(Amounts in thousands)		Three Months Ended						Nine Months Ended
		March 31, 2013			March 31, 2012			March 31, 2013			March 31, 2012
Segment Net Sales:
North America		$	158,746		$	145,154		$	701,380		$	625,215
International			105,738			94,125			375,564			347,524
Total		$	264,484		$	239,279		$	1,076,944		$	972,739
Segment Profit (Loss):
North America		$	20,998		$	20,818		$	111,348		$	105,133
International			(4,200	)		(4,932	)		14,070			8,975
Total		$	16,798		$	15,886		$	125,418		$	114,108
Reconciliation:
Segment Profit		$	16,798		$	15,886		$	125,418		$	114,108
Less:
Depreciation and Amortization			11,910			8,551			33,429			25,283
Interest Expense, net			5,893			5,291			18,515			16,339
Consolidation and Elimination          Adjustments			(142	)		(30	)		726			2,397
Unallocated Corporate Expenses			696	(1)		--			14,225	(2)		--
(Loss) Income Before Income Taxes		$	(1,559	)	$	2,074		$	58,523		$	70,089
(1)	Amounts for the three months ended March 31, 2013, include $0.6 million of inventory-related costs recorded in cost of sales primarily for inventory purchased by the Company from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and other assets from those companies, and other transition costs. An additional $0.1 million in transition expenses associated with such acquisitions were recorded in selling, general and administrative expenses.
(2)	Amounts for the nine months ended March 31, 2013, include $13.8 million of inventory-related costs ($6.4 million of which did not require the use of cash in the current period) recorded in cost of sales primarily for inventory purchased by the Company from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and other assets from those companies, and other transition costs. An additional $0.4 million in transition expenses associated with such acquisitions were recorded in selling, general and administrative expenses.

- 17-

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

          This discussion should be read in conjunction with the Unaudited Consolidated Financial Statements and related notes contained in this quarterly report and the Consolidated Financial Statements and related notes and the Management's Discussion and Analysis of Financial Condition and Results of Operations appearing in our Annual Report on Form 10-K for the year ended June 30, 2012. The results of operations for an interim period may not give a true indication of results for the year. In the following discussion, all comparisons are with the corresponding items in the prior year period.

Overview

          We are a global prestige beauty products company with an extensive portfolio of prestige fragrance, skin care and cosmetics brands. Our extensive product portfolio includes the following:

Elizabeth Arden Brand	The Elizabeth Arden skin care brands:Visible Difference, Ceramide,Prevage, andEight Hour Cream, Elizabeth Arden branded lipstick, foundation and other color cosmetics products, and the Elizabeth Arden fragrances:Red Door,Elizabeth Arden 5th Avenue, andElizabeth Arden green tea
Celebrity Fragrances	The fragrance brands of Britney Spears, Elizabeth Taylor, Mariah Carey, Taylor Swift, Justin Bieber, Nicki Minaj and Usher
Lifestyle Fragrances	Curve, Giorgio Beverly Hills, PS Fine Cologneand White Shoulders
Designer Fragrances	Juicy Couture, Alfred Sung, BCBGMAXAZRIA, Ed Hardy, Geoffrey Beene, Halston, John Varvatos, Kate Spade New York, Lucky, Rocawearand True Religion

          In addition to our owned and licensed fragrance brands, we distribute approximately 250 additional prestige fragrance brands, primarily in the United States, through distribution agreements and other purchasing arrangements.

          In May 2012, we acquired the global licenses and certain related assets, including inventory, for the Ed Hardy, True Religion and BCBGMAXAZRIA fragrance brands from New Wave Fragrances, LLC. Prior to the acquisition, we had been acting as a distributor of the Ed Hardy and True Religion fragrances to certain mid-tier and mass retailers in the North America.In June 2012, we also acquired the global licenses and certain assets related to the Justin Bieber and Nicki Minaj fragrance brands, including inventory of the Justin Bieber fragrances, from Give Back Brands LLC.Both of these transactions were accounted for as business combinations. Through the nine months ended March 31, 2013, we have incurred pre-tax transition and other expenses related to the New Wave LLC and Give Back Brands LLC acquisitions in fiscal 2013 of approximately $14.2 million ($6.4 million of which did not require the use of cash in the current fiscal year), and no additional such expenses are expected to be recorded during the remainder of fiscal 2013. These expenses primarily result from inventory purchased by us at a higher cost prior to the acquisitions, and other non-recurring expenses.

          For ease of reference in this Form 10-Q, the acquisitions from New Wave LLC and Give Back Brands LLC are referred to herein on a collective basis as the 2012 acquisitions.

          Our business strategy is currently focused on two important initiatives: the global repositioning of the Elizabeth Arden brand and expanding the market penetration of our prestige fragrance portfolio in international markets, especially in the large European fragrance market. We also intend to continue to increase net sales, operating margins and earnings by continuing to expand the prestige fragrance category at mass retail customers in North America and continuing to expand operating margins, working capital efficiency and return on invested capital. We believe that our focus on organic growth opportunities for our existing brands, new licensing opportunities and acquisitions, and new product innovation will assist us in achieving these goals.

         We are in the process of a comprehensive brand repositioning for the Elizabeth Arden brand, which is designed to honor the heritage of the brand while modernizing the brand's presentation and increasing its relevance among target consumers. The brand repositioning includes a revised product assortment, improved product formulations, package redesign, counter redesign, new advertising and marketing vehicles, and enhanced beauty advisor support. The initial roll-out was limited to a number of flagship retail doors. We began shipping the new product assortment to retailers in June 2012 and replaced most of such flagship retail counters with the new counters during the second quarter of fiscal 2013. During the remainder of fiscal 2013, we plan to substantially complete the process of introducing our new product assortment to our prestige retail customers, and to also extend elements of the new advertising, marketing and beauty advisor programs to the next tier of approximately 200 retail doors globally. We expect to extend elements of the new advertising, marketing and beauty advisor programs to additional retail doors beyond fiscal 2013. Based on

- 18 -

the results of the initial roll-out and plans for a more broad-based global roll-out, we may incur costs, expenses and capital expenditures in future periods that could be material to those periods. The specific facts and circumstances of the global roll- out will impact the timing and amount of any such costs, expenses and capital expenditures. Through the nine months ended March 31, 2013, we have incurred pre-tax non-recurring charges of $10.2 million associated with the Elizabeth Arden brand repositioning resulting from product assortment changes, and we currently expect to incur an additional $1.5 million of such costs in the fourth quarter of fiscal 2013.

          In September, 2012, we invested $5.5 million, including transaction costs, for a minority investment in Elizabeth Arden Salon Holdings, LLC, an unrelated entity whose subsidiaries operate the Elizabeth Arden Red Door Spas and the Mario Tricoci Hair Salons. In November 2012, we invested an additional $2.1 million. The investment was made with the intent of accelerating the growth of the spa business in parallel with the growth of the Elizabeth Arden brand and the Elizabeth Arden brand repositioning. The investment, which is in the form of a secured convertible note bearing interest at 2%, has been accounted for using the cost method and at March 31, 2013, is included in other assets on our unaudited consolidated balance sheet. Under the terms of the agreement with Salon Holdings, we expect to invest an additional $2.1 million in fiscal 2014.

          We continue to focus on (i) expanding gross margins through increased focus on product mix, improved pricing and reduced sales dilution, (ii) improving our sales and operations planning processes and our supply chain and logistics efficiency, and (iii) leveraging our overhead structure by increasing sales of our International segment. For fiscal 2013, we expect our gross margins to be approximately 130 to 170 basis points below our fiscal 2012 gross margins, including an estimated negative impact of 190 basis points for costs associated with the Elizabeth Arden brand repositioning and the 2012 acquisitions. This 190 basis point gross margin impact represents a year over year increase of 150 basis points relating to these costs.

          We manage our business by evaluating net sales, EBITDA (as defined later in this discussion), EBITDA margin, segment profit and working capital utilization (including monitoring our levels of inventory, accounts receivable, operating cash flow and return on invested capital). We encounter a variety of challenges that may affect our business and should be considered as described in Item 1A "Risk Factors" of our Annual Report on Form 10-K for the year ended June 30, 2012 and in the section of this quarterly report captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations -- Cautionary Note Regarding Forward-Looking Information and Factors That May Affect Future Results."

Seasonality

          Our operations have historically been seasonal, with higher sales generally occurring in the first half of our fiscal year as a result of increased demand by retailers in anticipation of and during the holiday season. For the year ended June 30, 2012, approximately 59% of our net sales were made during the first half of our fiscal year. Due to product innovation and new product launches, the size and timing of certain orders from our customers, and additions or losses of brand distribution rights, sales, results of operations, working capital requirements and cash flows can vary significantly between quarters of the same and different years. As a result, we expect to experience variability in net sales, operating margin, net income, working capital requirements and cash flows on a quarterly basis. Increased sales of skin care and cosmetic products relative to fragrances may reduce the seasonality of our business.

          We experience seasonality in our working capital, with peak inventory levels normally from July to October and peak receivable balances normally from September to December. Our working capital borrowings are also seasonal and are normally highest in the months of September, October and November. During the months of December, January and February of each year, cash is normally generated as customer payments on holiday season orders are received.

Critical Accounting Policies and Estimates

        As disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012, the discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in conformity with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses reported in those financial statements. We base our estimates on historical experience and other factors that we believe are most likely to occur. Changes in facts and circumstances may result in revised estimates, which are recorded in the period in which they become known. Our most critical accounting policies relate to revenue recognition, provisions for inventory obsolescence, allowances for sales returns, markdowns and doubtful accounts, intangible and long-lived assets, income taxes, hedging contracts and share-based compensation. Since June 30, 2012, there have been no significant changes to the assumptions and estimates related to those critical accounting policies.

- 19 -

Foreign Currency Contracts

          We operate in several foreign countries, which exposes us to market risk associated with foreign currency exchange rate fluctuations. Our risk management policy is to enter into cash flow hedges to reduce a portion of the exposure of our foreign subsidiaries' revenues to fluctuations in currency rates using foreign currency contracts. We also enter into cash flow hedges for a portion of our forecasted inventory purchases to reduce the exposure of our Canadian and Australian subsidiaries' cost of sales to such fluctuations, as well as cash flow hedges for a portion of our subsidiaries' forecasted Swiss franc operating costs. The principal currencies hedged are British pounds, Euros, Canadian dollars, Australian dollars and Swiss francs. We do not enter into derivative financial contracts for speculative or trading purposes.

          Changes to fair value of the foreign currency contracts are recorded as a component of accumulated other comprehensive income (loss) within shareholders' equity, to the extent such contracts are effective, and are recognized in net sales or cost of sales in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. Changes to fair value of any contracts deemed to be ineffective would be recognized in earnings immediately. There were no amounts recorded in the three and nine months ended March 31, 2013 or in fiscal 2012 relating to foreign currency contracts used to hedge forecasted revenues, forecasted cost of sales or forecasted operating costs resulting from hedge ineffectiveness.

          When appropriate, we also enter into and settle foreign currency contracts for Euros, British pounds and Canadian dollars to reduce exposure of our foreign subsidiaries' balance sheets to fluctuations in foreign currency rates. These contracts are used to hedge balance sheet exposure generally over one month and are settled before the end of the month in which they are entered into. Changes to fair value of the foreign currency contracts are recognized in selling, general and administrative expense in the period in which the contracts expire.

          The table below summarizes the effect of the pre-tax gain (loss) from our settled foreign currency contracts on the specified line items in our consolidated statements of income for the three and nine months ended March 31, 2013 and 2012.

(Amounts in thousands)	Three Months Ended						Nine Months Ended
	March 31, 2013			March 31, 2012			March 31, 2013			March 31, 2012
Net Sales	$	30		$	113		$	(160	)	$	180
Cost of Sales		(37	)		(342	)		(388	)		(1,140	)
Selling, general and administrative		778			(580	)		36			3
Total pre-tax gain (loss)	$	771		$	(809	)	$	(512	)	$	(957	)

American Taxpayer Relief Act of 2012

          On January 2, 2013, the American Taxpayer Relief Act of 2012 was signed into law by the President of the United States. Under the provisions of the American Taxpayer Relief Act of 2012, the research and development tax credit that had expired December 31, 2011, was reinstated retroactively to January 1, 2012, and is now scheduled to expire on December 31, 2013. We were required to record the impact of the extension of the research and development tax credit in the fiscal quarter beginning January 1, 2013. The impact of the extension of such tax credit is expected to result in a net tax benefit of approximately $0.5 million for the fiscal year ending June 30, 2013, of which $0.2 million was recorded as a discrete item in the third quarter of fiscal 2013.

- 20 -

Results of Operations

          The following discussion compares the historical results of operations for the three and nine months ended March 31, 2013 and 2012. Results of operations as a percentage of net sales were as follows (dollar amounts in thousands; percentages may not add due to rounding):

			Three Months Ended										Nine Months Ended
			March 31, 2013					March 31, 2012					March 31, 2013				March 31, 2012
Net sales			$	264,484		100.0	%	$	239,279		100.0	%	$	1,076,944	100.0	%	$	972,739	100.0	%
Cost of sales				136,643		51.7			118,781		49.6			562,220	52.2			489,548	50.3
Depreciation in cost of sales				1,656		0.6			906		0.4			4,674	0.4			3,850	0.4
	Gross profit(1)			126,185		47.7			119,592		50.0			510,050	47.4			479,341	49.3
Selling, general and administrative    expenses				111,597		42.2			104,582		43.7			404,257	37.6			371,480	38.2
Depreciation and amortization				10,254		3.9			7,645		3.2			28,755	2.7			21,433	2.2
	Income from operations(1)			4,334		1.6			7,365		3.1			77,038	7.1			86,428	8.9
Interest expense, net				5,893		2.2			5,291		2.2			18,515	1.7			16,339	1.7
	(Loss) income before income taxes			(1,559	)	(0.6	)		2,074		0.9			58,523	5.4			70,089	7.2
(Benefit from) provision for income    taxes				(286	)	--			(117	)	--			12,803	1.2			16,295	1.7
	Net (loss) income			(1,273	)	(0.5	)		2,191		0.9			45,720	4.2			53,794	5.5
Other data
EBITDA and EBITDA margin(2)			$	16,244		6.1	%	$	15,916		6.7	%	$	110,467	10.3	%	$	111,711	11.5	%
(1)		For the three months ended March 31, 2013, gross profit includes $0.6 million of inventory-related costs primarily for inventory purchased by us from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and certain other assets from those companies and other transition costs, and $2.8 million of non-recurring product changeover costs related to the repositioning of the Elizabeth Arden brand. In addition, income from operations includes $0.1 million in transition costs associated with the 2012 acquisitions and $0.1 million of non-recurring product changeover expenses, related to the repositioning of the Elizabeth Arden brand that were recorded in selling, general and administrative expenses. For the nine months ended March 31, 2013, gross profit includes $13.8 million of inventory-related costs ($6.4 million of which did not require the use of cash in the current period) primarily for inventory purchased by us from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and certain other assets from those companies and other transition costs, and $9.7 million of non-recurring product changeover costs related to the repositioning of the Elizabeth Arden brand. In addition, income from operations includes $0.4 million in transition costs associated with the 2012 acquisitions and $0.5 million of non-recurring product changeover expenses related to the repositioning of the Elizabeth Arden brand that were recorded in selling, general and administrative expenses.
(2)		For a definition of EBITDA and a reconciliation of net income (loss) to EBITDA, see "EBITDA" under Results of Operations -- Three Months Ended March 31, 2013 Compared to Three Months Ended March 31, 2012 and under Nine Months Ended March 31, 2013 compared to Nine Months Ended March 31, 2012. EBITDA margin represents EBITDA divided by net sales.

          Our operations are organized into the following two operating segments, which also comprise our reportable segments:

— North America - Our North America segment sells our portfolio of owned, licensed and distributed brands, including the Elizabeth Arden products, to department stores, mass retailers and distributors in the United States, Canada and Puerto Rico, and also includes the Company's direct to consumer business, which is composed of our Elizabeth Arden branded retail outlet stores and global e-commerce business. This segment also sells the Elizabeth Arden products through the Red Door beauty salons and spas, which are owned and operated by a third party in which we have a minority investment that licenses the Elizabeth Arden and Red Door trademarks from us for use in its salons and spas.

— International- Our International segment sells our portfolio of owned and licensed brands, including our Elizabeth Arden products, to perfumeries, boutiques, department stores, travel retail outlets and distributors in approximately 120 countries outside of North America.

- 21 -

          Segment profit (loss) excludes depreciation and amortization, interest expense, consolidation and elimination adjustments and unallocated corporate expenses, which are shown in the table reconciling segment profit to consolidated income before income taxes. Included in unallocated corporate expenses are (i) restructuring charges that are related to an announced plan, (ii) restructuring costs for corporate operations and (iii) acquisition-related costs including transition costs. These expenses are recorded in unallocated corporate expenses as these items are centrally directed and controlled and are not included in internal measures of segment operating performance. We do not have any intersegment sales.

          The following table is a comparative summary of our net sales and segment profit (loss) by operating segment for the three and nine months ended March 31, 2013 and 2012 and reflects the basis of presentation described in Note 13 -- "Segment Data and Related Information" to the Notes to Unaudited Consolidated Financial Statements for all periods presented.

(Amounts in thousands)		Three Months Ended						Nine Months Ended
		March 31, 2013			March 31, 2012			March 31, 2013			March 31, 2012
Segment Net Sales:
North America		$	158,746		$	145,154		$	701,380		$	625,215
International			105,738			94,125			375,564			347,524
Total		$	264,484		$	239,279		$	1,076,944		$	972,739
Segment Profit (Loss):
North America		$	20,998		$	20,818		$	111,348		$	105,133
International			(4,200	)		(4,932	)		14,070			8,975
Less:
Depreciation and Amortization			11,910			8,551			33,429			25,283
Interest Expense, net			5,893			5,291			18,515			16,339
Consolidation and Elimination            Adjustments			(142	)		(30	)		726			2,397
Unallocated Corporate Expenses(1)			696	(1)		--			14,225	(2)		--
Income Before Income Taxes		$	(1,559	)	$	2,074		$	58,523		$	70,089
(1)	Amounts for the three months ended March 31, 2013, include $0.6 million of inventory-related costs recorded in cost of sales primarily for inventory purchased by us from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and other assets from those companies, and other transition costs. An additional $0.1 million in transition expenses associated with such acquisitions were recorded in selling, general and administrative expenses.
(2)	Amounts for the nine months ended March 31, 2013, include $13.8 million of inventory-related costs ($6.4 million of which did not require the use of cash in the current period) recorded in cost of sales primarily for inventory purchased by us from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and other assets from those companies, and other transition costs. In addition, included in selling, general and administrative expenses are $0.4 million in transition expenses associated with such acquisitions.

          In light of the repositioning of the Elizabeth Arden brand commencing in fiscal 2013, we are providing the following additional net sales information relating to the following product categories: the Elizabeth Arden Brand (skin care, cosmetics and fragrances) and Celebrity, Lifestyle, Designer and Other Fragrances.

(Amounts in thousands)	Three Months Ended				Nine Months Ended
	March 31, 2013		March 31, 2012		March 31, 2013		March 31, 2012
Net Sales:
Elizabeth Arden Brand	$	106,239	$	106,082	$	362,675	$	363,948
Celebrity, Lifestyle, Designer and Other         Fragrances		158,245		133,197		714,269		608,791
Total	$	264,484	$	239,279	$	1,076,944	$	972,739

- 22 -

      Three Months Ended March 31, 2013 Compared to Three Months Ended March 31, 2012

          Net Sales.    Net sales increased by 10.5%, or $25.2 million, for the three months ended March 31, 2013, compared to the three months ended March 31, 2012. Excluding the unfavorable impact of foreign currency, net sales increased by 11.2%, or $26.9 million. Pricing changes had an immaterial effect on net sales. The following is a discussion of net sales by segments and product categories.

          Segment Net Sales:

          North America

          Net sales increased by 9.4%, or $13.6 million. The impact of foreign currency was not material. Net sales of licensed and non-Elizabeth Arden branded products increased by $16.6 million. The increase includes higher net sales of $10.8 million of the brands acquired in the 2012 acquisitions and $9.8 million due to the launches ofPinkFriday Nicki Minaj, Justin Bieber's Girlfriend and Ed Hardy Skull & Roses fragrances. Partially offsetting these increases were lower sales of Britney Spears fragrances. Net sales for Elizabeth Arden branded products increased by $1.0 million, due to higher net sales of color cosmetic products. Net sales of distributed brands were $4.1 million lower than the prior year period.

          International

          Net sales increased by 12.3%, or $11.6 million. Excluding the unfavorable impact of foreign currency, net sales increased by 13.9%, or $13.0 million. Net sales of licensed and non-Elizabeth Arden branded products increased an aggregate of $13.3 million primarily due to higher sales of Britney Spears, Justin Bieber and Nicki Minaj fragrances. Net sales for Elizabeth Arden branded products decreased by $0.9 million, due to lower sales of fragrance products, partially offset by higher sales of color cosmetic and skin care products. Our international results were led by higher net sales of $6.8 million in Europe and $3.9 million in distributor markets.

          Product Category Net Sales:

          Elizabeth Arden Brand

          Net sales were relatively flat as higher sales of color cosmetic products were primarily offset by lower sales of fragrances. Excluding the unfavorable impact of foreign currency, net sales increased by 0.7%, or $0.7 million. Net sales for color cosmetic products increased by 17.3%, or $2.7 million and net sales of fragrances decreased 5.1%, or $2.1 million.

          Celebrity, Lifestyle, Designer and Other Fragrances

          Net sales increased by 18.8%, or $25.0 million. Excluding the unfavorable impact of foreign currency, net sales increased by 19.6%, or $26.1 million. The increase includes higher net sales of (i) $14.7 million due to the launches ofPink FridayNicki Minaj, Justin Bieber's Girlfriend and Ed Hardy Skull & Roses fragrances, (ii) $13.7 million of brands acquired as part of the 2012 acquisitions, and (iii) $5.5 million from increased sales of John Varvatos,Taylor Swift and Juicy Couture fragrances. Partially offsetting these increases were $4.2 million of lower sales of distributed brands as well as lower sales of various other owned and licensed brands, including $2.9 million of lower sales of Britney Spears and Curve fragrances.

          Gross Margin.    For the three months ended March 31, 2013 and 2012 gross margins were 47.7% and 50.0%, respectively. Gross margin in the current year period was negatively impacted by $3.4 million, or 130 basis points, of inventory-related costs associated with the 2012 acquisitions and product changeover costs associated with the Elizabeth Arden brand repositioning. Gross margin also was negatively impacted in the current year period by higher discounts and allowances and higher freight costs.

          SG&A.   Selling, general and administrative expenses increased 6.7%, or $7.0 million, for the three months ended March 31, 2013, compared to the three months ended March 31, 2012. The increase was due to higher marketing and sales expenses of $12.2 million, partially offset by lower general and administrative expenses of $5.2 million. The increase in marketing and sales expenses was primarily due to higher advertising expenses primarily in support of the recently acquired brands and current fiscal year fragrance launches, higher marketing expenses related to the Elizabeth Arden brand repositioning, and higher royalty expenses due to increased sales of licensed brands. The decrease in general and administrative expenses was principally due to lower incentive compensation related costs of $7.8 million. The impact of foreign currency translation of our affiliates' balance sheets for the three months ended March 31, 2013 were losses of $0.8 million compared to gains of $0.2 million in the prior year period. Selling, general and administrative expenses for the three months ended March 31, 2013 also included $0.1 million of transition costs for the 2012 acquisitions and $0.1 million of product changeover expenses related to the Elizabeth Arden brand repositioning. For the three months ended March 31, 2013 and 2012, total share-based compensation costs charged against income for all stock plans was $1.4 million and $1.3 million, respectively.

- 23 -

Segment Profit

North America

          Segment profit increased slightly by 0.8% or $0.2 million. The increase in segment profit was due to higher gross profit, mostly offset by higher selling, general and administrative expenses, as further discussed above.

International

          Segment loss decreased by 14.8% or $0.7 million.The decrease in segment loss was due to higher gross profit, partially offset by higher selling, general and administrative expenses, as further discussed above.

          Depreciation and Amortization Expense.    Depreciation and amortization expense increased by 34.1% or $2.6 million, for the three months ended March 31, 2013, compared to the three months ended March 31, 2012, primarily due to higher amortization expense related to the 2012 acquisitions and higher depreciation expense for in-store counters and displays primarily related to the Elizabeth Arden brand repositioning.

          Interest Expense.    Interest expense, net of interest income, increased 11.4%, or $0.6 million, for the three months ended March 31, 2013, compared to the three months ended March 31, 2012. The increase was due to higheraverage borrowings under our revolving bank credit facility during the current year period due to the 2012 acquisitions.

          Provision for Income Taxes.   The pre-tax (loss) income from our domestic and international operations consisted of the following for the three months ended March 31, 2013 and 2012:

(Amounts in thousands)	Three Months Ended
	March 31, 2013			March 31, 2012
Domestic pre-tax loss	$	(4,827)		$	(4,695	)
Foreign pre-tax income		3,268			6,769
Total (loss) income before income taxes	$	(1,559)		$	2,074
Effective tax rate		18.3	%		5.6	%

          For interim reporting, the effective tax rate is based on expected full year reported earnings and considers earnings contribution by tax jurisdiction. As facts and circumstances change during the fiscal year that could impact the full year expected earnings or the expected earnings contribution by tax jurisdiction, the effective tax rate is adjusted in the period in which such changes become known or are enacted into law. Additionally, discrete items that could impact the effective tax rate are reported in the interim period incurred.

          The effective tax rate in the current year period was higher as compared to the prior year period due to a decrease in foreign operating income and a shift in the ratio of earnings contributions between foreign jurisdictions. In addition, during the third quarter of fiscal 2013, we recorded a discrete tax benefit of $0.2 million as a result of the American Taxpayer Relief Act of 2012, which was essentially offset by other discrete tax adjustments resulting from changes in estimates. The effective tax rate for the full fiscal year ended June 30, 2012 was 21.9%.

          A substantial portion of our consolidated taxable income is typically generated in Switzerland, where our international operations are headquartered and managed, and is taxed at a significantly lower effective tax rate than our domestic taxable income. As a result, any material shift in the relative proportion of our consolidated taxable income that is generated between the United States and Switzerland could have a material effect on our consolidated effective tax rate. We currently expect our reported effective tax rate for the year ending June 30, 2013 to be approximately 23.0%.

          Net (Loss) Income.    Net loss for the three months ended March 31, 2013, was $1.3 million compared to net income of $2.2 million for the three months ended March 31, 2012. The decrease in net income was primarily due to higher selling, general and administrative expenses and depreciation and amortization expense in the current year period.

- 24

          EBITDA.    EBITDA (net income plus the provision for income taxes (or net loss less the benefit from income taxes), plus interest expense, plus depreciation and amortization expense) of $16.2 million for the three months ended March 31, 2013, includes (i) $0.6 million of inventory-related costs recorded in cost of sales primarily for inventory purchased by us from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and certain other assets from those companies and other transition costs, (ii) $0.1 million in transition expenses recorded in selling, general and administrative expenses associated with such acquisitions, and (iii) $2.9 million of non-recurring product changeover costs and expenses related to the Elizabeth Arden brand repositioning. EBITDA for the three months ended March 31, 2012 was $15.9 million. The increase in EBITDA in the current year of approximately $0.3 million was primarily the result of higher gross profit, mostly offset by the higher selling, general and administrative expenses, as discussed above.

          EBITDA should not be considered as an alternative to operating income (loss) or net income (loss) (as determined in accordance with generally accepted accounting principles) as a measure of our operating performance or to net cash provided by operating, investing or financing activities (as determined in accordance with generally accepted accounting principles) or as a measure of our ability to meet cash needs. We believe that EBITDA is a measure commonly reported and widely used by investors and other interested parties as a measure of a company's operating performance and debt servicing ability because it assists in comparing performance on a consistent basis without regard to capital structure (particularly when acquisitions are involved), depreciation and amortization, or non-operating factors such as historical cost. Accordingly, as a result of our capital structure, we believe EBITDA is a relevant measure. This information has been disclosed here to permit a more complete comparative analysis of our operating performance relative to other companies and of our debt servicing ability. EBITDA may not, however, be comparable in all instances to other similar types of measures.

          In addition, EBITDA has limitations as an analytical tool, including the fact that:

— it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;

— it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;

— it does not reflect any cash income taxes that we may be required to pay; and

— although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future and these measures do not reflect any cash requirements for such replacements.

          The following is a reconciliation of net (loss) income, as determined in accordance with generally accepted accounting principles, to EBITDA:

(Amounts in thousands)			Three Months Ended
			March 31, 2013			March 31, 2012
Net (loss) income			$	(1,273	)	$	2,191
Plus:
	Benefit from income taxes			(286	)		(117	)
	Interest expense, net			5,893			5,291
	Depreciation in cost of sales			1,656			906
	Depreciation and amortization			10,254			7,645
		EBITDA	$	16,244		$	15,916

- 25 -

Nine Months Ended March 31, 2013 Compared to Nine Months Ended March 31, 2012

          Net Sales.    Net sales increased by 10.7%, or $104.2 million, for the nine months ended March 31, 2013, compared to the nine months ended March 31, 2012. Excluding the unfavorable impact of foreign currency, net sales increased by 11.8%, or $114.9 million. Pricing changes had an immaterial effect on net sales. The following is a discussion of net sales by segments and product categories.

          Segment Net Sales:

          North America

          Net sales increased by 12.2%, or $76.2 million. The impact of foreign currency was not material. Net sales of licensed and non-Elizabeth Arden branded products increased by $93.4 million. The increase includes higher net sales of (i) $54.0 million of the brands acquired in the 2012 acquisitions, (ii) $39.5 million due to the launches ofPinkFriday Nicki Minaj, Justin Bieber's Girlfriend and Ed Hardy Skull & Roses fragrances, and (iii) $32.7 million from higher sales of theJuicy CoutureandTaylor Swiftfragrances. Partially offsetting these increases were lower sales of various other owned and licensed brands, including $12.5 million of lower sales of Britney Spears and Mariah Carey fragrances. Net sales for Elizabeth Arden branded products decreased by $5.6 million, primarily due to lower sales of skin care products. Net sales of distributed brands were $11.6 million lower than the prior year period.

          International

          Net sales increased by 8.1%, or $28.0 million. Excluding the unfavorable impact of foreign currency, net sales increased by 11.1%, or $38.5 million. Net sales of licensed and non-Elizabeth Arden branded products increased an aggregate of $24.7 million primarily due to higher sales of Justin Bieber, Taylor Swift and John Varvatos fragrances, partially offset by lower sales of $9.7 million of Juicy Couture, Britney Spears and Mariah Carey fragrances. Net sales for Elizabeth Arden branded products increased by $4.3 million due to higher sales of skin care and fragrance products. Our international results were led by higher net sales of $17.9 million in Europe and $8.3 million in distributor markets.

          Product Category Net Sales:

          Elizabeth Arden Brand

          Net sales decreased by 0.3% or $1.3 million, due to lower sales of skin care products, partially offset by higher fragrance sales. Excluding the unfavorable impact of foreign currency, net sales increased by 1.4% or $5.1 million. Net sales for skin care products decreased by 1.7%, or $2.9 million due primarily to our wind down of retailer inventory in the early part of the current fiscal year in advance of the roll-out of the repositioning of the Elizabeth Arden brand. Net sales of fragrances increased 0.9%, or $1.3 million, led by higher sales ofRed Door fragrances.

          Celebrity, Lifestyle, Designer and Other Fragrances

          Net sales increased by 17.3% or $105.5 million. Excluding the unfavorable impact of foreign currency, net sales increased by 18.0% or $109.8 million. The increase includes higher net sales of (i) $67.2 million of brands acquired as part of the 2012 acquisitions, (ii) $53.8 million due to the launches ofJustin Bieber's Girlfriend,Pink FridayNicki Minajand Ed Hardy Skull & Roses fragrances, and (iii) $34.0 million from increased sales of Taylor Swift and Juicy Couture fragrances. Partially offsetting these increases were lower sales of various other owned and licensed brands, including $16.4 million of lower sales of Britney Spears and Mariah Carey fragrances, as well as $11.9 million of lower sales of distributed brands.

          Gross Margin.    For the nine months ended March 31, 2013 and 2012 gross margins were 47.4% and 49.3%, respectively. Gross margin in the current year period was negatively impacted by $23.5 million, or 210 basis points, of inventory-related costs ($6.4 million of which did not require the use of cash in the current period) associated with the 2012 acquisitions and product changeover costs associated with the Elizabeth Arden brand repositioning. Gross margin benefited in the current year period from a higher proportion of basic sales of licensed products, which reflect higher gross margins as compared to distributed brands.

          SG&A.    Selling, general and administrative expenses increased 8.8%, or $32.8 million, for the nine months ended March 31, 2013, compared to the nine months ended March 31, 2012. The increase was due to higher marketing and sales expenses of $47.9 million, partially offset by lower general and administrative expenses of $15.1 million. The increase in marketing and sales expenses was primarily due to higher advertising, media and sales promotion expenses due to higher spend in support of the recently acquired brands and current fiscal year fragrance launches, higher marketing expenses related to the Elizabeth Arden brand repositioning, and higher royalty expenses due to increased sales of licensed brands. The decrease in general and administrative expenses was principally

- 26-

due to lower incentive compensation related costs of $11.6 million and the impact of foreign currency translation of our affiliates' balance sheets as the current year included losses of $0.7 million compared to losses of $4.0 million in the prior year period. The nine months ended March 31, 2013 also included $0.4 million of transition costs for the 2012 acquisitions and $0.5 million of product changeover expenses related to the Elizabeth Arden brand repositioning. For the nine months ended March 31, 2013 and 2012, total share-based compensation costs charged against income for all stock plans was $4.2 million and $3.8 million, respectively.

Segment Profit

North America

       Segment profit increased 5.9% or $6.2 million. The increase in segment profit was due to higher gross profit, partially offset by higher selling, general and administrative expenses, as further discussed above.

International

      Segment profit increased by 56.8% or $5.1 million.The increase in segment profit was due to higher gross profit, partially offset by higher selling, general and administrative expenses, as further discussed above.

          Depreciation and Amortization Expense.    Depreciation and amortization expense increased by 34.2% or $7.3 million, for the nine months ended March 31, 2013, compared to the nine months ended March 31, 2012, primarily due to higher amortization expense related to the 2012 acquisitions and higher depreciation expense for in-store counters and displays primarily related to the Elizabeth Arden brand repositioning.

          Interest Expense.    Interest expense, net of interest income, increased 13.3%, or $2.2 million, for the nine months ended March 31, 2013, compared to the nine months ended March 31, 2012. The increase was due to higheraverage borrowings under our revolving bank credit facility during the current year period due to the 2012 acquisitions and interest under our second lien credit agreement which we initially borrowed against on July 2, 2012.

          Provision for Income Taxes.    The pre-tax income from our domestic and international operations consisted of the following for the nine months ended March 31, 2013 and 2012:

(Amounts in thousands)	Nine Months Ended
	March 31, 2013			March 31, 2012
Domestic pre-tax income	$	19,287		$	29,509
Foreign pre-tax income		39,236			40,580
Total income before income taxes	$	58,523		$	70,089
Effective tax rate		21.9	%		23.2	%

          For interim reporting, the effective tax rate is based on expected full year reported earnings and considers earnings contribution by tax jurisdiction. As facts and circumstances change during the fiscal year that could impact the full year expected earnings or the expected earnings contribution by tax jurisdiction, the effective tax rate is adjusted in the period in which such changes become known or are enacted into law. Additionally, discrete items that could impact the effective tax rate are reported in the interim period incurred.

         The effective tax rate in the current year period was lower as compared to the prior year period due to a decrease in domestic operating income and a shift in the ratio of earnings contributions between foreign jurisdictions. The results for the nine months ended March 31, 2013 include a discrete tax benefit of $0.2 million as a result of the American Taxpayer Relief Act of 2012, which was essentially offset by other discrete tax adjustments resulting from changes in estimates. The effective tax rate for the full fiscal year ended June 30, 2012 was 21.9%.

          A substantial portion of our consolidated taxable income is typically generated in Switzerland, where our international operations are headquartered and managed, and is taxed at a significantly lower effective tax rate than our domestic taxable income. As a result, any material shift in the relative proportion of our consolidated taxable income that is generated between the United States and Switzerland could have a material effect on our consolidated effective tax rate. We currently expect our reported effective tax rate for the year ending June 30, 2013 to be approximately 23.0%.

          Net Income.    Net income for the nine months ended March 31, 2013, was $45.7 million compared to $53.8 million for the nine months ended March 31, 2012. The decrease in the net income was primarily due to higher selling, general and administrative expenses and higher depreciation and amortization expense, partially offset by higher gross profit and the lower effective tax rate in the current year period.

- 27-

          EBITDA.    EBITDA (net income plus the provision for income taxes (or net loss less the benefit from income taxes), plus interest expense, plus depreciation and amortization expense) of $110.5 million for the nine months ended March 31, 2013, includes (i) $13.8 million of inventory-related costs ($6.4 million of which did not require the use of cash in the current period) recorded in cost of sales primarily for inventory purchased by us from New Wave Fragrances LLC and Give Back Brands LLC prior to the acquisition of licenses and certain other assets from those companies and other transition costs, (ii) $0.4 million in transition expenses recorded in selling, general and administrative expenses associated with such acquisitions, and (iii) $10.2 million of non-recurring product changeover costs and expenses related to the Elizabeth Arden brand. EBITDA for the nine months ended March 31, 2012 was $111.7 million. The decrease in EBITDA in the current year of approximately $1.2 million was primarily the result of higher selling, general and administrative expenses, mostly offset by higher gross profit, as discussed above.

          The following is a reconciliation of net income, as determined in accordance with generally accepted accounting principles, to EBITDA:

(Amounts in thousands)			Nine Months Ended
			March 31, 2013		March 31, 2012
Net income			$	45,720	$	53,794
Plus:
	Provision for income taxes			12,803		16,295
	Interest expense, net			18,515		16,339
	Depreciation in cost of sales			4,674		3,850
	Depreciation and amortization			28,755		21,433
		EBITDA	$	110,467	$	111,711

          The following is a reconciliation of net cash flow (used in) provided by operating activities, as determined in accordance with generally accepted accounting principles, to EBITDA:

(Amounts in thousands)	Nine Months Ended
	March 31, 2013				March 31, 2012
Net cash (used in) provided by operating activities	$	(8,848	)	��	$	50,331
Changes in assets and liabilities, net of acquisitions		99,639				45,318
Interest expense, net		18,515				16,339
Amortization of senior note offering and credit facility costs		(1,024	)			(931	)
Provision for income taxes		12,803				16,295
Deferred income taxes		(6,371	)			(11,883	)
Amortization of share-based awards		(4,247	)			(3,758	)
EBITDA	$	110,467			$	111,711

Liquidity and Capital Resources

          The following chart summarizes our cash flows (outflows) from operating, investing and financing activities for the nine months ended March 31, 2013 and 2012:

(Amounts in thousands)	Nine Months Ended
	March 31, 2013			March 31, 2012
Net cash (used in) provided by operating activities	$	(8,848	)	$	50,331
Net cash used in investing activities		(38,456	)		(60,685	)
Net cash provided by financing activities		20,410			10,919
Net decrease in cash and cash equivalents		(27,638	)		(643	)

Operating Activities

          Cash (used in) provided by our operating activities is driven by net income adjusted for non-cash expenses and changes in working capital. The following chart illustrates our net cash (used in) provided by operating activities for the nine months ended March 31, 2013 and 2012:

- 28 -

(Amounts in thousands)	Nine Months Ended
	March 31, 2013			March 31, 2012
Net income	$	45,720		$	53,794
Net adjustments to reconcile net income to net cash    provided by operating activities		45,071			41,855
Net change in assets and liabilities, net of acquisition    ("working capital changes")		(99,639	)		(45,318	)
Net cash (used in) provided by operating activities	$	(8,848	)	$	50,331

          For the nine months ended March 31, 2013, net cash used by operating activities was $8.8 million, as compared to net cash provided by operating activities of $50.3 million for the nine months ended March 31, 2012. Net income decreased by $8.1 million and net adjustments to reconcile net income to cash used in operating activities increased by $3.2 million, as compared to the prior year. Working capital changes utilized cash of $99.6 million in the current year period as compared to $45.3 million in the prior year. The increase in cash utilized by working capital changes primarily related to (i) a larger increase in accounts receivable due to the increase in and timing of sales in the current year period, (ii) a larger aggregate decrease in accounts payable and other accrued liabilities primarily due to the timing of payments, and (iii) higher inventory purchases in the current year primarily due to the brand repositioning for Elizabeth Arden and the requirements for brands acquired in the 2012 acquisitions.

Investing Activities

          The following chart illustrates our net cash used in investing activities for the nine months ended March 31, 2013 and 2012:

(Amounts in thousands)	Nine Months Ended
	March 31, 2013			March 31, 2012
Additions to property and equipment	$	(30,388	)	$	(16,785	)
Acquisition of intangible and other assets		(8,068	)		(43,900	)
Net cash used in investing activities	$	(38,456	)	$	(60,685	)

          For the nine months ended March 31, 2013, net cash used in investing activities of $38.5 million was composed of (i) $30.4 million of capital expenditures, (ii) $7.6 million associated with a minority investment in Elizabeth Arden Salon Holdings, LLC, an unrelated entity whose subsidiaries operate the Red Door beauty salons and spas, and (iii) $0.5 million for the acquisition of a license for a cosmetic formula. For the nine months ended March 31, 2012, net cash used in investing activities of $60.7 million was composed of (i) $16.8 million of capital expenditures, and (ii) $43.9 million related to the August 2011 acquisition of trademarks for theCurvefragrance brands and certain other smaller fragrance brands and the amendment to the license agreement with Liz Claiborne.  The increase in capital expenditures for the nine months ended March 31, 2013 is primarily due to expenditures incurred for in-store counters and displays related to the Elizabeth Arden brand repositioning and tools and molds for new fragrance launches.

Financing Activities

          The following chart illustrates our net cash provided by financing activities for the nine months ended March 31, 2013 and 2012:

(Amounts in thousands)	Nine Months Ended
	March 31, 2013			March 31, 2012
Proceeds from short-term debt	$	27,050		$	--
Repurchase of common stock		(12,515	)		--
Proceeds from the exercise of stock options		4,693			5,258
Payments of contingent consideration related to acquisition		(4,960	)		--
All other financing activities		6,142			5,661
Net cash provided by financing activities	$	20,410		$	10,919

- 29 -

          For the nine months ended March 31, 2013, net cash provided by financing activities was $20.4 million, as compared to $10.9 million for the nine months ended March 31, 2012. During the nine months ended March 31, 2013, borrowings under our credit facility increased by $27.1 million from a balance of $89.2 million at June 30, 2012. During the nine months ended March 31, 2012, borrowings under our credit facility remained unchanged from a zero balance at June 30, 2011. For the nine months ended March 31, 2013, repurchases of common stock totaled $12.5 million and payments of contingent consideration related to the fiscal 2012 acquisition of global licenses and certain other assets of Give Back Brands LLC totaled $5.0 million. Proceeds from the exercise of stock options were $4.7 million in the current year period as compared to $5.3 million in the prior year period.

          Interest paid during the nine months ended March 31, 2013, included $18.4 million of interest payments on the 7 3/8% senior notes due 2021, $2.7 million of interest paid on the borrowings under our credit facility and $0.7 million of interest paid on our second lien term loan. Interest paid during the nine months ended March 31, 2012, included $21.2 million of interest payments on the 7 3/8% senior notes due 2021 and $1.7 million of interest paid on the borrowings under our credit facility.

          At March 31, 2013, we had approximately $31.4 million of cash, of which $22.5 million was held outside of the United States, primarily in South Africa and Switzerland. The cash held outside the U.S. was needed to meet local working capital requirements and therefore considered permanently reinvested in the applicable local subsidiary.

          Future Liquidity and Capital Needs.    Our principal future uses of funds are for working capital requirements, including brand and product development and marketing expenses, new product launches, additional brand acquisitions or product licensing and distribution arrangements, capital expenditures and debt service. In addition, we may use funds to repurchase material amounts of our common stock and senior notes through open market purchases, privately negotiated transactions or otherwise, depending upon prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. We have historically financed our working capital needs primarily through internally generated funds, our credit facility and external financing. We collect cash from our customers based on our sales to them and their respective payment terms.

          We have a $300 million revolving bank credit facility with a syndicate of banks, for which JPMorgan Chase Bank is the administrative agent, which generally provides for borrowings on a revolving basis, with a sub-limit of $25 million for letters of credit. See Note 8 to the Unaudited Notes to Consolidated Financial Statements. Under the terms of the credit facility, we may, at any time, increase the size of the credit facility up to $375 million without entering into a formal amendment requiring the consent of all of the banks, subject to our satisfaction of certain conditions. The credit facility was amended in June 2012 to allow for the contingent consideration that may become payable with respect to the acquisition of certain assets of Give Back Brands LLC and to allow for the second lien facility further discussed below. The credit facility expires in January 2016.

          The credit facility is guaranteed by all of our U.S. subsidiaries and is collateralized by a first priority lien on all of our U.S. accounts receivable and inventory. Borrowings under the credit facility are limited to 85% of eligible accounts receivable and 85% of the appraised net liquidation value of our inventory, as determined pursuant to the terms of the credit facility; provided, however, that from August 15 to October 31 of each year, our borrowing base may be temporarily increased by up to $25 million.

          The credit facility has only one financial maintenance covenant, which is a debt service coverage ratio that must be maintained at not less than 1.1 to 1 if average borrowing base capacity declines to less than $25 million ($35 million from September 1 through January 31). Our average borrowing base capacity for the quarter ended March 31, 2013 did not fall below the applicable threshold noted above. Accordingly, the debt service coverage ratio did not apply for the quarter ended March 31, 2013. We were in compliance with all applicable covenants under the credit facility for the quarter ended March 31, 2013.

          Under the terms of the credit facility, we may pay dividends or repurchase common stock if we maintain borrowing base capacity of at least $25 million from February 1 to August 31, and at least $35 million from September 1 to January 31, after making the applicable payment. The credit facility restricts us from incurring additional non-trade indebtedness (other than refinancings and certain small amounts of indebtedness).

          Borrowings under the credit portion of the credit facility bear interest at a floating rate based on an "Applicable Margin" which is determined by reference to a debt service coverage ratio. At our option, the Applicable Margin may be applied to either the London InterBank Offered Rate (LIBOR) or the base rate (which is comparable to prime rates). The Applicable Margin ranges from 1.75% to 2.50% for LIBOR loans and from 0.25% to 1.0% for base rate loans, except that the Applicable Margin on the first $25 million of borrowings from August 15 to October 31 of each year, while the temporary increase in our borrowing base is in effect, is 1.0% higher. We are required to pay an unused commitment fee ranging from 0.375% to 0.50% based on the quarterly average unused portion of the credit facility. The interest rates payable by us on our 7 3/8% senior notes and on borrowings under our revolving credit facility and second lien facility are not impacted by credit rating agency actions.

- 30

-

          At March 31, 2013, the Applicable Margin under our revolving credit facility was 1.75% for LIBOR loans and 0.25% for base rate loans. The commitment fee on the unused portion of the credit facility at March 31, 2013 was 0.50%. For both the nine months ended March 31, 2013 and 2012, the weighted average annual interest rate on borrowings under the credit facility was 2.1%.

          In connection with the 2012 acquisitions of fragrance licenses and certain other assets from New Wave Fragrances LLC and Give Back Brands LLC, on June 12, 2012, the Company entered into a second lien facility agreement with JPMorgan Chase Bank, N.A. providing us with the ability to borrow up to $30 million on or prior to July 2, 2012. On July 2, 2012, we borrowed $30 million under this facility agreement and used the proceeds to repay amounts under our credit facility. The second lien facility is collateralized by a second priority lien on all of our U.S. accounts receivable and inventories and the interest on borrowings charged under the second lien facility was either (i) LIBOR plus an applicable margin of 3.75% or (ii) the base rate specified in the second lien facility (which is comparable to prime rates) plus a margin of 2.75%. We had the option to prepay all or a portion of the second lien facility anytime after February 1, 2013, provided the borrowing base capacity under the credit facility was in excess of $35 million after giving effect to the applicable prepayment each day for the 30 day period ending on the date of the prepayment. The second lien facility matures on July 2, 2014.

          On February 11, 2013 we prepaid all of the amounts outstanding under the second lien facility and amended the second lien facility to allow for borrowings of up to $30 million on a revolving basis until its maturity. The amendment also reduced the interest on borrowings on the second lien facility to (i) LIBOR plus an applicable margin of 3.25% or (ii) the base rate specified in the second lien facility (which is comparable to prime rates) plus a margin of 1.75%. The unused commitment fee applicable to the second lien facility ranges from 0.25% to 0.375%. To the extent we borrow amounts under the second lien facility, we have the option to prepay all or a portion of such borrowings, provided the borrowing base capacity under the credit facility is in excess of $35 million after giving effect to the applicable prepayment each day for the 30 day period ending on the date of the prepayment. At March 31, 2013, we had no outstanding borrowings under the second lien facility.

          At March 31, 2013, we had $116.3 million in borrowings and $3.3 million in letters of credit outstanding under the credit facility. At March 31, 2013, based on eligible accounts receivable and inventory available as collateral, an additional $77.3 million in the aggregate could be borrowed under our credit facility and our second lien facility. The borrowing base capacity under the credit facility typically declines in the second half of our fiscal year as our higher accounts receivable balances resulting from holiday season sales are likely to decline due to cash collections.

          At March 31, 2013, we had outstanding $250 million aggregate principal amount of 7 3/8% senior notes due March 2021. Interest on the 7 3/8% senior notes accrues at a rate of 7.375% per annum and is payable semi-annually on March 15 and September 15 of every year. The 7 3/8% senior notes rank pari passu in right of payment to indebtedness under our credit facility and any other senior debt, and will rank senior to any future subordinated indebtedness; provided, however, that the 7 3/8% senior notes are effectively subordinated to the credit facility and the second lien facility to the extent of the collateral securing the credit facility and the second lien facility. The indenture applicable to the 7 3/8% senior notes generally permits us (subject to the satisfaction of a fixed charge coverage ratio and, in certain cases, also a net income test) to incur additional indebtedness, pay dividends, purchase or redeem our common stock or redeem subordinated indebtedness. The indenture generally limits our ability to create liens, merge or transfer or sell assets. The indenture also provides that the holders of the 7 3/8% senior notes have the option to require us to repurchase their notes in the event of a change of control involving us (as defined in the indenture). The 7 3/8% senior notes initially will not be guaranteed by any of our subsidiaries but could become guaranteed in the future by any domestic subsidiary of ours that guarantees or incurs certain indebtedness in excess of $10 million.

          Based upon our internal projections, we believe that existing cash and cash equivalents, internally generated funds and borrowings under our credit facility and the second lien facility will be sufficient to cover debt service, working capital requirements and capital expenditures for the next twelve months, other than additional working capital requirements that may result from further expansion of our operations through acquisitions of additional brands or licensing or distribution arrangements. A deterioration in the economic and retail environment, however, could cause us to fail to satisfy the financial maintenance covenant under our credit facility that applies only in the event we do not have the requisite average borrowing base capacity as set forth under the credit facility. In such an event, we would not be allowed to borrow under the credit facility and may not have access to the capital necessary for our business. In addition, a default under our credit facility or the second lien facility that causes acceleration of the debt under either facility could trigger a default under our outstanding 7 3/8% senior notes. In the event we are not able to borrow under either borrowing facility, we would be required to develop an alternative source of liquidity. There is no assurance that we could obtain replacement financing or what the terms of such financing, if available, would be.

- 31 -

          We have discussions from time to time with manufacturers and owners of prestige fragrance brands regarding our possible acquisition of additional trademark, exclusive licensing and/or distribution rights. We currently have no material agreements or commitments with respect to any such acquisition, although we periodically execute routine agreements to maintain the confidentiality of information obtained during the course of discussions with such manufacturers and brand owners. There is no assurance that we will be able to negotiate successfully for any such future acquisitions or that we will be able to obtain acquisition financing or additional working capital financing on satisfactory terms for further expansion of our operations.

          Repurchases of Common Stock.    On November 2, 2010, our board of directors authorized the repurchase of an additional $40 million of our common stock under the terms of an existing $80 million common stock repurchase program and extended the term of the stock repurchase program from November 30, 2010 to November 30, 2012. On August 7, 2012, our board of directors approved an extension of the stock repurchase program through November 30, 2014.

          During the three months ended March 31, 2013, we purchased 322,882 shares of common stock on the open market under the stock repurchase program at an average price of $38.76 per share and at a cost of $12.5 million, including sales commissions. As of March 31, 2013, we had repurchased 4,352,083 shares of common stock on the open market under the stock repurchase program, at an average price of $18.27 per share and at a cost of approximately $79.5 million, including sales commissions, leaving approximately $40.5 million available for additional repurchases under the program. The acquisition of these shares by us was accounted for under the treasury method.

Cautionary Note Regarding Forward-Looking Information and Factors That May Affect Future Results

The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company's future prospects and make informed investment decisions. This Quarterly Report on Form 10-Q and other written and oral statements that we make from time to time contain such forward-looking statements that set out anticipated results based on management's plans and assumptions regarding future events or performance. We have tried, wherever possible, to identify such statements by using words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," "will" and similar expressions in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, prospective products, future performance or results of current and anticipated products, sales efforts, expenses and/or cost savings, interest rates, foreign exchange rates, the outcome of contingencies, such as legal proceedings, and financial results. A list of factors that could cause our actual results of operations and financial condition to differ materially is set forth below, and these factors are discussed in greater detail under Item 1A -- "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended June 30, 2012:

*	factors affecting our relationships with our customers or our customers' businesses, including the absence of contracts with customers, our customers' financial condition, and changes in the retail, fragrance and cosmetic industries, such as the consolidation of retailers and the associated closing of retail doors as well as retailer inventory control practices, including, but not limited to, levels of inventory carried at point of sale and practices used to control inventory shrinkage;
*	risks of international operations, including foreign currency fluctuations, hedging activities, economic and political consequences of terrorist attacks, disruptions in travel, unfavorable changes in U.S. or international laws or regulations, diseases and pandemics, and political instability in certain regions of the world;
*	our reliance on license agreements with third parties for the rights to sell many of our prestige fragrance brands;
*	our reliance on third-party manufacturers for substantially all of our owned and licensed products and our absence of contracts with suppliers of distributed brands and components for manufacturing of owned and licensed brands;
*	delays in shipments, inventory shortages and higher supply chain costs due to the loss of or disruption in our distribution facilities or at key third party manufacturing or fulfillment facilities that manufacture or provide logistic services for our products;
*	our ability to respond in a timely manner to changing consumer preferences and purchasing patterns and other international and domestic conditions and events that impact retailer and/or consumer confidence and demand, such as domestic or global recessions or economic uncertainty;
*	our ability to protect our intellectual property rights;
*	the success, or changes in the timing or scope, of our new product launches, advertising and merchandising programs;
*	the quality, safety and efficacy of our products;
*	the impact of competitive products and pricing;

- 32 -

*	our ability to (i) implement our growth strategy and acquire or license additional brands or secure additional distribution arrangements, (ii) successfully and cost-effectively integrate acquired businesses or new brands, and (iii) finance our growth strategy and our working capital requirements;
*	our level of indebtedness, our ability to realize sufficient cash flows from operations to meet our debt service obligations and working capital requirements, and restrictive covenants in our revolving credit facility, second lien facility and the indenture for our 7 3/8% senior notes;
*	changes in product mix to less profitable products;
*	the retention and availability of key personnel;
*	changes in the legal, regulatory and political environment that impact, or will impact, our business, including changes to customs or trade regulations, laws or regulations relating to ingredients or other chemicals or raw materials contained in products or packaging, or accounting standards or critical accounting estimates;
*	the success of our Elizabeth Arden brand repositioning efforts;
*	the impact of tax audits, including the ultimate outcome of the pending Internal Revenue Service examination of our U.S. federal tax returns for the fiscal years ended June 30, 2008 and June 30, 2009, changes in tax laws or tax rates, and our ability to utilize our deferred tax assets;
*	our ability to effectively implement, manage and maintain our global information systems and maintain the security of our confidential data and our employees' and customers' personal information;
*	our reliance on certain third parties for certain outsourced business services, including information technology operations, logistics management and employee benefit plan administration;
*	the potential for significant impairment charges relating to our trademarks, goodwill or other intangible assets that could result from a number of factors, including downward pressure on our stock price; and
*	other unanticipated risks and uncertainties.

          We caution that the factors described herein and other factors could cause our actual results of operations and financial condition to differ materially from those expressed in any forward-looking statements we make and that investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all of such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

          As of March 31, 2013, we had $116.3 million in borrowings outstanding under our revolving credit facility and no outstanding balances under our second lien facility. Borrowings under our revolving credit facility are seasonal, with peak borrowings typically in the months of September, October and November. Borrowings under the credit facility and second lien term facility are subject to variable rates and, accordingly, our earnings and cash flow will be affected by changes in interest rates. Based upon our average borrowings under our revolving credit facility and second lien facility during the nine months ended March 31, 2013, and assuming there had been a two percentage point (200 basis point) change in the average interest rate for these borrowings, it is estimated that our interest expense for the nine months ended March 31, 2013 would have increased or decreased by approximately $2.2 million. See Note 8 to the Notes to Unaudited Consolidated Financial Statements.

Foreign Currency Risk

          We sell our products in approximately 120 countries around the world. During the three and nine months ended March 31, 2013, we derived approximately 46% and 40%, respectively of our net sales from our international operations. We conduct our international operations in a variety of different countries and derive our sales in various currencies including the Euro, British pound, Swiss franc, Canadian dollar and Australian dollar, as well as the U.S. dollar. Most of our skin care and cosmetic products are produced in third-party manufacturing facilities located in the U.S. Our operations may be subject to volatility because of currency changes, inflation and changes in political and economic conditions in the countries in which we operate. With respect to international operations, our sales, cost of goods sold and expenses are typically denominated in a combination of local currency and the U.S.

- 33 -

dollar. Our results of operations are reported in U.S. dollars. Fluctuations in currency rates can affect our reported sales, margins, operating costs and the anticipated settlement of our foreign denominated receivables and payables. A weakening of the foreign currencies in which we generate sales relative to the currencies in which our costs are denominated, which is primarily the U.S. dollar, may adversely affect our ability to meet our obligations and could adversely affect our business, prospects, results of operations, financial condition or cash flows. Our competitors may or may not be subject to the same fluctuations in currency rates, and our competitive position could be affected by these changes.

          As of March 31, 2013, we had notional amounts of 8.3 million British pounds and 12.5 million Euros under open foreign currency contracts, all of which expire between April 30, 2013 and May 31, 2014 to reduce the exposure of our foreign subsidiary revenues to fluctuations in currency rates. As of March 31, 2013, we had notional amounts under foreign currency contracts of (i) 1.1 million Canadian dollars and 1.0 million Australian dollars used to hedge forecasted cost of sales, and (ii) 14.7 million Swiss francs used to hedge forecasted operating costs, all of which expire between April 30, 2013 and May 31, 2014. We have designated each qualifying foreign currency contract as a cash flow hedge. The gains and losses of these contracts will only be recognized in earnings in the period in which the forecasted transaction affects earnings or the transactions are no longer probable of occurring. The realized gain, net of taxes, recognized during the three months ended March 31, 2013 from settled contracts was $48,000 and the realized loss, net of taxes recognized during the nine months ended March 31, 2013 from settled contracts was approximately $0.4 million. At March 31, 2013, the unrealized gain, net of taxes, associated with these open contracts of approximately $0.9 million is included in accumulated other comprehensive income in our consolidated balance sheet. See Notes 2 and 11 to the Notes to Unaudited Consolidated Financial Statements.

          When appropriate, we also enter into and settle foreign currency contracts for Euros, British pounds, Canadian dollars and Australian dollars to reduce the exposure of our foreign subsidiaries' balance sheets to fluctuations in foreign currency rates. As of March 31, 2013, there were no such foreign currency contracts outstanding. The realized gain, net of taxes, recognized during the three and nine months ended March 31, 2013 were $0.6 million and $23,000, respectively, from the settlement of these contracts.

          We do not utilize foreign currency contracts for trading or speculative purposes. There can be no assurance that our hedging operations or other exchange rate practices, if any, will eliminate or substantially reduce risks associated with fluctuating currency exchange rates.

ITEM 4.    CONTROLS AND PROCEDURES

          Our Chairman, President and Chief Executive Officer, and our Executive Vice President and Chief Financial Officer, who are the principal executive officer and principal financial officer, respectively, have evaluated the effectiveness and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended), as of the end of the period covered by this quarterly report (the "Evaluation Date"). Based upon such evaluation, they have concluded that, as of the Evaluation Date, our disclosure controls and procedures are functioning effectively.

          There have been no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II.    OTHER INFORMATION

ITEM 1A.    RISK FACTORS

          Risk factors describing the major risks to our business can be found under Item 1A, "Risk Factors," in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012. There has been no material change in our risk factors from those previously discussed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2012.

- 34 -

ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

          This table provides information with respect to our purchases of shares of our common stock, $.01 par value per share, during the three months ended March 31, 2013.

Issuer Purchases of Equity Securities
		(a)	(b)		(c)	(d)
Period		Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)	Approximate Dollar Value that May Yet Be Purchased Under the Plans or Programs(2)
January 1, 2013 through January 31, 2013		--	$	N/A	--	$	53,002,474
February 1, 2013 through February 28, 2013		227,000	$	38.84	227,000	$	44,185,531
March 1, 2013 through March 31, 2013		95,882	$	38.57	95,882	$	40,487,332
Totals		322,882	$	18.27	322,882	$	40,487,332
(1)	On November 2, 2010, our board of directors authorized the repurchase of an additional $40 million of our common stock under the terms of an existing $80 million common stock repurchase program and extended the term of the stock repurchase program from November 30, 2010 to November 30, 2012. On August 7, 2012, our board of directors approved an extension of the stock repurchase program through November 30, 2014. All shares purchased during the quarter ended March 31, 2013 were purchased on the open market.
(2)	Amounts reflect the remaining dollar value of shares that may be purchased under the stock repurchase program described above.

ITEM 5.    OTHER INFORMATION

          On March 11, 2013, the compensation committee of our board of directors authorized the payment of certain compensation and benefits to Ms. Kathleen Widmer, our Executive Vice President and Chief Marketing Officer, as a retention incentive. The authorized compensation and benefits consist of (i) payment of a lump sum cash retention award of approximately $636,000, which award is subject to repayment in full (a) should Ms. Widmer no longer be employed by us prior to June 30, 2018 (other than after a change of control of our company), or (b) should she fail to comply with certain non-competition and non-solicitation obligations prior to June 30, 2018; (ii) payment of a monthly housing allowance of $5,000 per month, retroactive to July 1, 2012 and continuing through June 30, 2017; and (iii) reimbursement of certain relocation expenses and related taxes, including moving and temporary housing expenses, associated with Ms. Widmer's relocation to a home closer to our New York office.

- 35 -

ITEM 6.EXHIBITS

Exhibit Number	Description
3.1	Amended and Restated Articles of Incorporation of the Company dated November 17, 2005 (incorporated herein by reference to Exhibit 3.1 filed as part of the Company's Form 10-Q for the quarter ended December 31, 2005 (Commission File No. 1-6370)).
3.2	Amended and Restated By-laws of the Company (incorporated herein by reference to Exhibit 3.1 filed as part of the Company's Form 8-K dated October 27, 2009 (Commission File No. 1-6370)).
4.1	Indenture, dated as of January 21, 2011, respecting Elizabeth Arden, Inc.'s 7 3/8% Senior Notes due 2021, among Elizabeth Arden, Inc. and U.S. Bank National Association, as trustee (incorporated herein by reference to Exhibit 4.1 to the Company's Form 8-K dated January 21, 2011 (Commission File No. 1-6370)).
10.1	Third Amended and Restated Credit Agreement, dated as of January 21, 2011, among Elizabeth Arden, Inc., as borrower, JP Morgan Chase Bank, N.A., as administrative agent, Bank of America, N.A., as collateral agent and syndication agent, Wells Fargo Capital Finance, LLC, HSBC Bank USA, N.A. and U.S. Bank National Association, as co-documentation agents, JPMorgan Chase Bank, N.A., and Bank of America, N.A. as joint lead arrangers, and the other lenders party thereto (incorporated herein by reference to Exhibit 10.1 filed as part of the Company's Form 8-K dated January 21, 2011 (Commission File No. 1-6370)).
10.2	Amended and Restated Security Agreement dated as of January 29, 2001, made by the Company and certain of its subsidiaries in favor of Fleet National Bank (n/k/a Bank of America, N.A.), as administrative agent (incorporated herein by reference to Exhibit 4.5 filed as part of the Company's Form 8-K dated January 23, 2001 (Commission File No. 1-6370)).
10.3	First Amendment to Third Amended and Restated Credit Agreement dated as of June 12, 2012, among Elizabeth Arden, Inc., as Borrower, JPMorgan Chase Bank, N.A., as the administrative agent, Bank of America, N.A., as the collateral agent, and the other banks party thereto (incorporated by reference to Exhibit 10.3 filed as part of the Company's Form 10-K for the year ended June 30, 2012 (Commission File No. 1-6370)).
10.4	Credit Agreement (Second Lien) dated as of June 12, 2012, between Elizabeth Arden, Inc. and JPMorgan Chase Bank, N.A.(incorporated by reference to Exhibit 10.4 filed as part of the Company's Form 10-K for the year ended June 30, 2012 (Commission File No. 1-6370)).
10.5 *	First Amendment to Credit Agreement (Second Lien) dated as of February 11, 2013, between Elizabeth Arden, Inc. and JPMorgan Chase Bank N.A.
10.6	Amended and Restated Deed of Lease dated as of January 17, 2003, between the Company and Liberty Property Limited Partnership (incorporated herein by referenced to Exhibit 10.5 filed as a part of the Company's Form 10-Q for the quarter ended April 26, 2003 (Commission File No. 1-6370)).
10.7	Amendment to the Amended and Restated Deed of Lease dated as of June 30, 2012, between the Company and Liberty Property Limited Partnership (incorporated by reference to Exhibit 10.6 filed as part of the Company's Form 10-K for the year ended June 30, 2012 (Commission File No. 1-6370)).
10.8+	2004 Stock Incentive Plan, as amended and restated (incorporated herein by reference to Exhibit 10.12 filed as part of the Company's Form 10-Q for the quarter ended December 31, 2007 (Commission File No. 1-6370)).
10.9+	2004 Non-Employee Director Stock Option Plan, as amended (incorporated herein by reference to Exhibit 10.2 filed as part of the Company's Form 10-Q for the quarter ended September 30, 2006 (Commission File No. 1-6370)).
10.10+	2000 Stock Incentive Plan, as amended (incorporated herein by reference to Exhibit 10.14 filed as part of the Company's Form 10-Q for the quarter ended December 31, 2007 (Commission File No. 1-6370)).
10.11+	1995 Stock Option Plan, as amended (incorporated herein by reference to Exhibit 10.4 filed as part of the Company's Form 10-Q for the quarter ended September 30, 2006 (Commission File No. 1-6370)).
10.12+	2011 Employee Stock Purchase Plan (incorporated herein by reference to Exhibit 4.3 filed as part of the Company's Form S-8, Registration No. 333-177839, dated November 9, 2011 (Commission File No. 1-6370)).

- 36 -

Exhibit Number	Description
10.13+	Non-Employee Director Stock Option Plan, as amended (incorporated herein by reference to Exhibit 10.6 filed as part of the Company's Form 10-Q for the quarter ended September 30, 2006 (Commission File No. 1-6370)).
10.14+	Form of Nonqualified Stock Option Agreement for stock option awards under the Company's Non-Employee Director Stock Option Plan (incorporated herein by reference to Exhibit 10.8 filed as a part of the Company's Form 10-Q for the quarter ended March 31, 2005 (Commission File No. 1-6370)).
10.15 +	Form of Incentive Stock Option Agreement for stock option awards under the Company's 1995 Stock Option Plan (incorporated herein by reference to Exhibit 10.9 filed as a part of the Company's Form 10-Q for the quarter ended March 31, 2005 (Commission File No. 1-6370)).
10.16 +	Form of Nonqualified Stock Option Agreement for stock option awards under the Company's 1995 Stock Option Plan (incorporated herein by reference to Exhibit 10.10 filed as a part of the Company's Form 10-Q for the quarter ended March 31, 2005 (Commission File No. 1-6370)).
10.17 +	Form of Stock Option Agreement for stock option awards under the Company's 2000 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.11 filed as a part of the Company's Form 10-Q for the quarter ended March 31, 2005 (Commission File No. 1-6370)).
10.18 +	Form of Stock Option Agreement for stock option awards under the Company's 2004 Non-Employee Director Stock Option Plan (incorporated herein by reference to Exhibit 10.14 filed as a part of the Company's Form 10-Q for the quarter ended March 31, 2005 (Commission File No. 1-6370)).
10.19 +	Form of Stock Option Agreement for stock option awards under the Company's 2004 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.19 filed as a part of the Company's Form 10-K for the year ended June 30, 2005 (Commission File No. 1-6370)).
10.20 +	Form of Restricted Stock Agreement for the restricted stock awards under the Company's 2004 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.20 filed as a part of the Company's Form 10-K for the year ended June 30, 2005 (Commission File No. 1-6370)).
10.21 +	Elizabeth Arden, Inc. Severance Policy, as amended and restated on May 4, 2010 (incorporated herein by reference to Exhibit 10.31 filed as part of the Company's Form 10-Q for the quarter ended March 31, 2010 (Commission File No. 1-6370)).
10.22 +	Form of Restricted Stock Agreement for service-based restricted stock awards (three-year vesting period) under the Company's 2000 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.32 filed as part of the Company's Form 10-K for the year ended June 30, 2007 (Commission File No. 1-6370)).
10.23 +	Form of Indemnification Agreement for Directors and Officers of Elizabeth Arden, Inc. (incorporated by reference to Exhibit 10.1 filed as part of the Company's Form 8-K dated August 11, 2009 (Commission File No. 1-6370)).
10.24 +	Elizabeth Arden Inc. 2010 Stock Award and Incentive Plan (incorporated by reference to Exhibit 4.3 filed as part of the Company's Form S-8, Registration No. 333-170287, filed on November 2, 2010 (Commission File No. 1-6370)).
10.25 +	Form of Restricted Stock Agreement for service-based stock awards under the Company's 2010 Stock Award and Incentive Plan (incorporated herein by reference to Exhibit 10.35 filed as part of the Company's Form 10-Q for the quarter ended September 30, 2010 (Commission File No. 1-6370)).
10.26 +	Form of Restricted Stock Unit Agreement for restricted stock unit awards under the Company's 2010 Stock Award and Incentive Plan (incorporated herein by reference to Exhibit 10.22 filed as part of the Company's Form 10-Q for the quarter ended September 30, 2011 (Commission File No. 1-6370)).
10.27 +	Form of Restricted Stock Unit Agreement for restricted stock unit awards under the Company's 2004 Stock Incentive Plan (incorporated herein by reference to Exhibit 10.26 filed as part of the Company's Form 10-Q for the quarter ended September 30, 2012 (Commission File No. 1-6370)).
10.28+*	Letter Agreement between Elizabeth Arden, Inc. and Kathleen Widmer, dated March 19, 2013, regarding 2013 retention payment.

- 37 -

Exhibit Number	Description
31.1 *	Section 302 Certification of Chief Executive Officer.
31.2 *	Section 302 Certification of Chief Financial Officer.
32 *	Section 906 Certifications of the Chief Executive Officer and the Chief Financial Officer.
101.INS **	XBRL Instance Document
101.SCH **	XBRL Taxonomy Extension Schema Document
101.CAL **	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF **	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB **	XBRL Taxonomy Extension Label Linkbase Document
101.PRE **	XBRL Taxonomy Extension Presentation Linkbase Document

+	Management contract or compensatory plan or arrangement.
*	Filed herewith.
**	Filed herewith as Exhibit 101 are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) unaudited consolidated balance sheets as of March 31, 2013 and June 30, 2012, (ii) unaudited consolidated statements of operations for each the three and nine months ended March 31, 2013 and 2012, (iii) unaudited consolidated statements of comprehensive (loss) income for each of the three and nine months ended March 31, 2013 and 2012, (iv) unaudited consolidated statements of cash flows for the nine months ended March 31, 2013 and 2012, respectively, and (v) the notes to the unaudited consolidated financial statements. Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities Exchange Act of 1934 and otherwise are not subject to liability.

- 38 -

SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ELIZABETH ARDEN, INC.
Date: May 3, 2013	/s/ E. Scott Beattie
	E. Scott Beattie
	Chairman, President and Chief Executive Officer
	(Principal Executive Officer)
Date:  May 3, 2013	/s/ Stephen J. Smith
	Stephen J. Smith
	Executive Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

- 39 -

EXHIBIT INDEX

Exhibit Number	Description
10.5	First Amendment to Credit Agreement (Second Lien) dated as of February 11, 2013, between Elizabeth Arden, Inc. and JPMorgan Chase Bank N.A.
10.28	Letter Agreement between Elizabeth Arden, Inc. and Kathleen Widmer, dated March 19, 2013, regarding 2013 retention payment.
31.1	Section 302 Certification of Chief Executive Officer.
31.2	Section 302 Certification of Chief Financial Officer.
32	Section 906 Certifications of the Chief Executive Officer and the Chief Financial Officer.
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

- 40 -